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Cervical cancer is a major public health problem in developing countries. In Guyana, factors 
associated with increasing cervical cancer cases among Indigenous Amerindian women 
(IAW), Afro- women (AGW), and Indo-Guyanese women (IGW) have not been fully 
examined. In this comparative cross-sectional study, 5,800 cervical cancer cases were 
selected from Guyanese women age 13 and above for ethnicity (Indigenous Amerindian, 
Afro- and Indo Guyanese women), geographical region, marital status, and year and stage at 
diagnosis. Secondary data from Guyana Cancer Registry for the 2000-2012 study periods 
were analyzed using chi-square test, multinomial logistic regression, poisson regression, and 
relative risk. Geographical region was a strong predictor of cervical cancer cases for all three 
ethnic groups (p < 0.05). The relative risk for cervical cancer for IAW in Regions 2 (RR = 
1.2) and 6 (RR = 1.07) was greater than for IAW in Region 4, the reference group for the 
study period. Comparatively, the relative risk for cervical cancer for AGW in Region 4 was 
greater than AGW in all other regions except Region 3 (RR = 1.05). Additionally, the relative 
risk for cervical cancer for IGW in Region 3 (RR = 1.03) was greater than that of IGW in all 
other regions. Single IAW (1.05) have a higher risk of getting cervical cancer than their 
married counterparts as compared to AGW (0.96) and IGW (1.00). Implications for social 
change include development of tailored programs which utilize a socio-ecological model 
to address cervical cancer issues at the individual, interpersonal, cultural, and community 
levels. Future research should focus on understanding the epidemiology of cervical 
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Chapter 1: Introduction to the Study 
Introduction 
Cervical cancer is a disease that occurs when precancerous or neoplastic cells of 
the cervix, also known as cervical intraepithelial neoplasia (CIN), are infected with the 
human papillomavirus (HPV; Adams & Carnright, 2013; Tran et al., 2011). Researchers 
have identified HPV, the most common type of sexually transmitted infection (STI; 
Adams & Carnright, 2013; Crosbie, Einstein, Franceschi, & Kitchener, 2013; Lewis-Bell 
et al., 2013; Warman, 2010) as the primary cause of cervical cancer worldwide (Adams 
& Carnright, 2013; Andall-Brereton et al., 2011; Dascau et al., 2012; Eze, Umeora, 
Obuna, Egwuatu, & Ejikeme, 2012; Franco et al., 2006; Khan et al., 2005; Lewis-Bell et 
al., 2013; Ragin et al., 2007; Tiffen & Mahon, 2006; Warman, 2010). It has been detected 
in 99% of all invasive cervical cancer (Adams & Carnright, 2013; Tiffen & Mahon, 
2006). These viruses are transmitted through sexual contact (Adams & Carnright, 2013; 
Cutts et al., 2007) and have prevalence rates of 19-46% (Cuzick et al., 1995; Hildesheim 
et al., 1993; Ho, Bierman, Beardsley, Chang, & Burk, 1998). HPVs include many 
subtypes, some classified as high-risk types and others as low-risk types that are unlikely 
to cause invasive cervical cancer (Adams & Carnright, 2013; Andall-Brereton et al., 
2011; Crosbie et al., 2013; Munoz, Castellsague, deGonzalez, & Gissman, 2006; Tiffen 
& Mahon, 2006). Anogenital cancers are high-risk types of cancers (Spitzer, 2006) that 
are associated with the progression of precancerous lesions to invasive cervical cancer 
(Adams & Carnright, 2013; Andall-Brereton et al., 2011; Ragin et al., 2007; Tiffen & 





papillomatosis, infections that go unnoticed or eventually go away, and benign or low-
grade cervical cell changes that can result in mild Papanicolaou (Pap) test abnormalities 
(Andall-Brereton et al., 2011; Spitzer, 2006; Tiffen & Mahon, 2006). HPV 16 and HPV 
18 are two high-risk types of HPV that have been associated with over 70% of all 
cervical cancer cases worldwide (Crosbie et al., 2013; Lewis-Bell et al., 2013; Bruni et 
al., 2015).  
The two most common types of cervical cancer, squamous cell carcinoma which 
takes place in the squamocolumnar junction or ectocervix, and adenocarcinoma which 
develops in the glandular cells of the endocervix, are responsible for 70% and 25% of 
cervical cancer respectively (Adams & Carnright, 2013). Squamous cell carcinomas of 
the ectocervix are also reportedly related to HPV infection (Dascau et al., 2012). HPV 
infection is not the only known risk factor that contributes to the development of cervical 
cancer. Many related research studies have also identified other factors associated with an 
increased risk of developing cervical cancer (Adams & Carnright, 2013; Castellsaguѐ, 
Bosch, & Muñoz, 2002; Crosbie et al., 2013; Eze et al., 2012; Lee, So, Piyathilake, & 
Kim, 2013; Luo et al., 2012; Tiffen & Mahon, 2006; Warman, 2010). These include first 
intercourse at an early age, trachomatis infection, herpes simplex virus, HIV/AIDS, diet, 
smoking, long-term use of oral contraceptives, multiple sex partners, multiple full-term 
pregnancies, poverty, family history of cervical cancer, multiparity, use of 








Cervical cancer is a preventable disease. Since the introduction of the 
Papanicolaou (Pap) smear programs in 1941, deaths resulting from cervical cancer have 
declined by 70% in developed countries (Devesa et al., 1987; Richart, 1995). Pap smears 
help to detect cervical changes due to premalignant forms of squamous cell cervical 
cancer (Akers, Newman, & Smith, 2007). Cervical cancer, the third most common cancer 
that occurs among women in developing countries (Jemal, Center, DeSantis, & Ward, 
2010; Pierce Campbell, Curado, Harlow, & Soliman, 2010), is responsible for premature 
death and cancer death among women in these countries (Correnti et al., 2011; Jemal et 
al., 2010). The highest incidences of cervical cancer in the world are found in Latin 
American and Caribbean countries (Almonte et al., 2008; Franco et al., 2008) whose 
mortality rates are seven times the cervical cancer mortality rates of North American 
countries (Luciani & Andrus, 2008), with an average regional estimate of 29.2 cases per 
100,000 women based on the 2002 data (Almonte et al., 2008). This large regional 
variation in cervical cancer rates reflects geographic differences in HPV prevalence 
and/or the availability of Pap test screening (Jemal et al., 2010).  
 Cervical cancer is common in Guyana, the only English-speaking country in 
South America which lies on the northern Atlantic coast between Venezuela and Surinam 
(Best Plummer, Persaud & Layne, 2009. According to public health statistics from 
Guyana, women (272,382) who are 15 years and older are at risk of developing cervical 
cancer (Bruni et al., 2013). The impact of this disease is evident in the number of deaths 





Statistics on the estimated incidence and mortality of cervical cancer cases in Guyana 
indicated that for 2012, “about 161 new cervical cancer cases are diagnosed annually in 
Guyana” (Bruni et al., 2013, p. 6) and “about 71 cervical cancer deaths occur annually” 
(Bruni et al., 2013, p. 14). By the year 2025, these rates are expected to increase, with an 
annual rate of 201 new cases and 99 deaths resulting from cervical cancer in Guyana 
(WHO/ICO Information Centre, 2010).The Indigenous Amerindian women of Guyana 
who reside in the rural and remote parts of the country have a high prevalence of high-
risk HPV and also suffer from a higher prevalence of cervical cancer as compared to 
other demographic groups in Guyana (Kightlinger et al., 2010). The reason for this high 
prevalence is unclear (Kightlinger et al., 2010); therefore, understanding the burden of 
HPV infection and the high prevalence of cervical cancer within this population is 
important. Data from population-based cancer registries could provide insight into 
understanding cervical cancer rates within geographically diverse areas (Pierce-Campbell 
et al., 2012). The geographic and sociodemographic data obtained from the cancer 
registry in Guyana could potentially lead to a better understanding of the high incidence 
of cervical cancer existing within this indigenous population of women. 
 
Problem Statement 
In developing countries, cervical cancer is a significant public health problem 
(Correnti et al., 2011; Jemal et al., 2010; Luciani & Andrus, 2008; Reynales-Shigematsu, 
Rodrigues, & Lazcano-Ponce, 2009; Watt et al., 2009; Winkler et al., 2008) because of a 





Luciani & Andrus, 2008; Vaccarella, Lortet-Tieulent, Plummer, Franceschi, & Bray, 
2013). Cervical cancer is the second most common cause of cancer occurring among 
women in the world (Anorlu, 2008; Jia et al., 2013; Khan et al., 2005; Qmichou et al., 
2013; Sabir, Hassan, & Hussain, 2013; Tiffen & Mahon, 2006; Warman, 2010; World 
Health Organization, 2013a) and is responsible for 250,000 deaths and 500,000 newly 
diagnosed cases each year (Eze et al., 2012; Jia et al., 2013; Sabir et al., 2013). In 
developing countries, however, the rate of cervical cancer is reportedly very high (Adams 
& Carnright, 2013; Jia et al., 2013; Qmichou et al., 2013; Sabir et al., 2013) and is 
blamed for 80% of the incident of cervical cancer cases worldwide (Adams & Carnright, 
2013; Eze et al., 2012; Sabir et al., 2013), and 85% of cervical cancer deaths annually 
(Eze et al., 2012; Tran et al., 2011; World Health Organization, 2013a). 
While the incidence and mortality of cervical cancer in developed countries have 
reportedly decreased (Anorlu, 2008; McDougall & Andall, 2002; Pierce Campbell et al., 
2012), the prevalence of this disease continues to have a serious impact in developing 
countries (Anorlu, 2008; Jemal et al., 2010; Pierce Campbell et al., 2012) with high rates 
reported in countries located in Central and South America, the Caribbean, sub-Saharan 
Africa, and Southern Asia (Almonte et al., 2008; Correnti et al., 2011; Luciani & Andrus, 
2008; Pierce Campbell et al., 2012). In Guyana, the estimated incidence of cervical 
cancer in 2008 was 43.3 per 100,000 women per year, while the mortality rate was 19.9 
per 100,000 women per year as compared to 11.2 per 100,000 women per year for other 
regions in South America, and 8.2 per 100,000 globally (WHO/ICO Information Centre, 





Cervical cancer, if left untreated, could have serious consequences on women’s 
health, possibly leading to death. Indigenous Amerindian women in Guyana have a high 
rate of cervical cancer and high-grade dysplasia (Kightlinger et al., 2010). The 
Kightlinger et al. (2010) study was limited to an assessment of 16 cervical cancer cases 
(out of the 2250 Indigenous Amerindian women screened). The total Indigenous 
Amerindian population within the regions of Kightlinger et al.’s (2010) study was less 
than 40,000 (Guyana Bureau of Statistics, 2015a). Factors such as low socioeconomic 
status, intercourse at a very early age, numerous childbirths, poverty, and limited access 
to health care are risk factors for cervical cancer among these Indigenous women (Best 
Plummer et al., 2009). Since these women reside in the remote and rural regions of 
Guyana, access to large-scale cytologic cervical cancer screening has been hampered by 
many factors such as insufficient funding needed to address the healthcare and routine 
screening needs of these women, lack of laboratory infrastructure, and geographic and 
logistic barriers to medical care in areas that are difficult to travel as a result of poor 
roadways (Kightlinger et al., 2010). Additionally, Goss et al. (2013) reported that the 
health ministries and healthcare systems in Latin American and Caribbean countries also 
experience many challenges in caring for patients with advanced cancer. These 
challenges include “inadequate funding; inequitable distribution of resources and 
services; inadequate numbers, training, and distribution of health-care personnel and 
equipment; and lack of adequate care for many populations based on socioeconomic, 





It is unclear whether HPV is sexually transmitted and causally associated with 
cervical cancer in Guyana. According to the WHO/ICO HPV Information Centre (2010), 
data on the burden of HPV in the general population of Guyana is not yet available, but in 
South America, the region that Guyana belongs to, the disease may be latent among 
13.2% of the women in the general population (WHO/ICO HPV Information Centre, 
2010). Very little research has been conducted to address the high incidence of cervical 
cancer among IAW, AGW, and IGW in Guyana, and researchers have indicated the need 
for further investigation of cervical cancer rates in these three ethnic groups (Best 
Plummer et al., 2009; Kightlinger et al., 2010). To address this gap in research regarding 
the high incidence of cervical cancer among IAW, AGW, and IGW, I conducted a review 
of the Guyana Cancer Registry’s database, as well as examined studies focusing on the 
ethnic and site prevalence of cervical, prostate and breast cancers, and the prevalence of 
cervical cancer disease, human papillomavirus infection, and human papillomavirus 
(HPV) genotypes in indigenous villages of Guyana (Kightlinger et al., 2010). Both of 
these studies suggested that further investigation on the high incidence of cervical cancer 
among these three ethnic groups of women is necessary. 
Nature of the Study 
In this quantitative study, I measured variables pertaining to age, marital status, 
geographical regions, stage at diagnosis, and their association with the cervical cancer 
cases. This study targeted IAW, AGW, and IGW who live in Guyana. Cases included all 
three ethnic groups of Guyanese women who were diagnosed with invasive cervical 





lesions, and low-grade squamous intraepithelial lesions with laboratory confirmation. In 
addition, I included all IAW, AGW, and IGW ages 13 years and over who were 
diagnosed with cervical cancer between 2000 and 2012 and reported to the Guyana 
Cancer Registry. Exclusion from the study was based on age (<13 years), and previous 
diagnosis or treatment for cervical cancer. I discussed methodology and research design 
in Chapter 3 of this study. 
Research Questions and Hypothesis 
 RQ1: Is there a difference in cervical cancer cases for Indigenous Amerindian 
women compared to Afro- and Indo-Guyanese women from 2000 through 2012?  
H1: There will be a significant difference in cervical cancer cases for Indigenous 
Amerindian women when compared to Afro- and Indo-Guyanese women from 2000 
through 2012. 
H01: There is no significant difference in cervical cancer cases for Indigenous 
Amerindian women when compared to Afro- and Indo-Guyanese women from 2000 
through 2012. 
HA1: There is a statistically significant difference in cervical cancer cases for 
Indigenous Amerindian women when compared to Afro- and Indo-Guyanese women 
from 2000 through 2012. 
RQ2: Is there an association between cervical cancer cases among Indigenous 






H2: There will be a significant association between cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women and 
their geographical regions. 
H02: There is no significant association between cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women and 
their geographical regions. 
RQ3: Is there a relationship in cervical cancer cases among Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women according to 
their ages, marital status, and year of diagnosis?  
H3A: There will be a significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to their ages, marital status, and year of diagnosis. 
H3B: There will be a significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to their age. 
H03B: There is no significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to their age. 
H3C: There will be a significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 





H03C: There is no significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to their marital status. 
H3D: There will be a significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to year of diagnosis. 
H03D: There is no significant relationship in cervical cancer cases among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women 
according to year of diagnosis. 
RQ4: Is there an association between the stage at diagnosis of cervical cancer and 
age, marital status, year of diagnosis, and geographical region among Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women? 
H4: There will be a significant association between the stage at diagnosis of 
cervical cancer and age, marital status, year of diagnosis, and geographical region among 
Indigenous Amerindian women, Afro-Guyanese women, and Indo-Guyanese women. 
H4A:  There will be a significant association between the stage at diagnosis of 
cervical cancer and age among Indigenous Amerindian women, Afro-Guyanese women, 
and Indo-Guyanese women. 
H04A: There is no significant association between the stage at diagnosis of cervical 






H4B: There will be a significant association between the stage at diagnosis of 
cervical cancer and marital status among Indigenous Amerindian women, Afro-Guyanese 
women, and Indo-Guyanese women. 
H04B: There is no significant association between the stage at diagnosis of cervical 
cancer and marital status among Indigenous Amerindian women, Afro-Guyanese women, 
and Indo-Guyanese women. 
H4C: There will be a significant association between the stage at diagnosis of 
cervical cancer and year of diagnosis among Indigenous Amerindian women, Afro-
Guyanese women, and Indo-Guyanese women. 
H04C: There is no significant association between the stage at diagnosis of cervical 
cancer and year of diagnosis among Indigenous Amerindian women, Afro-Guyanese 
women, and Indo-Guyanese women. 
H4D: There will be a significant association between the stage at diagnosis of 
cervical cancer and geographical region among Indigenous Amerindian women, Afro-
Guyanese women, and Indo-Guyanese women. 
H04D: There is no significant association between the stage at diagnosis of cervical 
cancer and geographical region among Indigenous Amerindian women, Afro-Guyanese 
women, and Indo-Guyanese women. 
Purpose of the Study 
 The purpose of this study was to use secondary data from the Guyana Cancer 
Registry to examine the demographic variables and their relationship to cervical cancer 





women in Guyana. The dependent variable was cervical cancer and the independent 
variables were age, marital status, geographical regions, and stage at diagnosis of cervical 
cancer.  
Conceptual Framework 
I used the health belief model (HBM) as the theoretical framework in this study. 
The HBM is one of the oldest and most widely used theories to explain the change in 
health behavior (Schiavo, 2007). In this study, the premise of the HBM constructs were 
appropriate for addressing the following behavior change among IAW, AGW, and IGW: 
a) perceived susceptibility and perceived severity in relation to cervical cancer; b) 
perceived benefits in terms of their willingness to be screened for cervical cancer. Being 
screened can reduce the risk of acquiring cervical cancer, improve quality of life, and 
reduce the incidence and mortality of cervical cancer; c) perceived barriers in terms of 
lack of finance, fear in getting screened, language barrier, cultural beliefs, and 
transportation issues; d) cues to action such as health education messages through 
culturally appropriate channels to respond or take action for cervical cancer screening; 
and e) self-efficacy to build confidence in maintaining the behavior change (Schiavo, 
2007). According to Glanz, Rimer, and Viswanath (2008), demographic variables may 
influence perception and thus indirectly influence health-related behavior. Glanz and 
colleagues (2008) further note that sociodemographic factors, for example, educational 
attainment, could have an indirect effect on behavior by influencing the perception of 





In Guyana, ethnic groups who reside in the rural areas are disproportionately 
affected by limited access to health care, poverty, and poor health outcomes. As 
compared to other ethnic groups who live in urban areas and areas where better and 
easier transportation facilities are provided, the Amerindians who reside in the rural areas 
experience difficulty accessing health clinics because doing so requires extensive travel 
(Kightlinger et al., 2010). Poverty also disproportionately affects the Amerindians who 
reportedly experience the highest incidence of poverty when compared to other ethnic 
groups in urban areas (Pan American Health Organization [PAHO], 2013a). There are 
also marked differences in health outcomes between the different ethnic groups in 
Guyana. Ischemic heart disease is the major cause of death among individuals of Indo-
Guyanese, Chinese, and Portuguese ethnicity, while mortality due to neoplasms and 
AIDS are major causes of death among Afro-Guyanese and Amerindian ethnicities 
(PAHO, 2013a). According to a study conducted on the racial differences in physical and 
mental well-being in Guyana, Indo-Guyanese were found to have significantly higher 
levels of impairment when compared to Afro-Guyanese (Wilson, Wilson, & Johnson, 
2010). In addition, the Guyana Cancer Registry reported that cervical cancer incidence in 
Afro- and Indo-Guyanese women were similar, while cases of cervical cancer were 
significantly higher among Amerindian women as compared to Afro- and Indo-Guyanese 
women (Best Plummer et al., 2009).  
Operational Definitions 





 Adenocarcinoma: Cancer that begins in glandular (secretory) cells (National 
Cancer Institute, n.d. a).  
Amerindians: A race of Indians from South America who are descendants of the 
people who gradually inhabited the wild coast of the Guiana region (Menezes, 1979) 
Cervical cancer: Cancer that forms in tissues of the cervix, the organ connecting 
the uterus and vagina (National Cancer Institute, n.d. b). 
 Cervical dysplasia: A condition that relates to the abnormal changes in the cells 
on the surface of the cervix (A.D.A.M. Medical Encyclopedia, 2013a). 
Cervix: The lower part of the uterus (womb) that opens at the top of the vagina 
(A.D.A.M. Medical Encyclopedia, 2013b). 
 Cervical intraepithelial neoplasia: A condition caused by certain types of HPV 
(National Cancer Institute, n.d. c). 
 Distant stage or Stage IV: A designation for when the cancer has spread to other 
parts of the body (National Cancer Institute, 2015).  
Dysplasia: A condition in which cells change from being normal cells to 
abnormal cells (National Cancer Institute, 2013a). 
 Ectocervix: The part of the cervix next to the vagina (American Cancer Society, 
2013a). 
 Ethnicity: A social group characterized by a distinct social and cultural tradition 
maintained within the group from generation to generation, that has a common history 





Human papillomavirus (HPV): A type of virus that causes abnormal tissue growth 
and other changes to cells (National Cancer Institute, n.d. d). 
 Indigenous: People are considered indigenous either because they are descendants 
of those who lived in the area at the time of conquest or before colonization, or because 
they have maintained their own social, economic, cultural and political institutions since 
colonization and the establishment of new states (International Labor Organization, 
Convention 169, 2012). 
 In-situ (Stage 0): A designation for when abnormal cells are found in the 
innermost lining of the cervix (National Cancer Institute, 2015). 
 Invasive cervical cancer: A cancer that originates in but spreads beyond the 
cervix (American Cancer Society, 2013b). 
 Neoplasia: Abnormal new cell growth which can be benign or malignant 
(American Cancer Society, 2014a). 
Papanicolaou (Pap) test: A test used as the main screening for cervical cancer 
and pre-cancerous changes (American Cancer Society, 2013a). 
 Precancerous conditions: Cellular conditions that may become cancer (National 
Cancer Institute, 2013b). 
Race: A group or a person who belong(s) to as a result of a mix of physical 
features, such as skin color and hair texture, which are associated with ancestry and 





Sexually Transmitted Infections (STIs): Infections that are transmitted through 
sexual contact including vaginal, oral, and anal sex (Lazarus, Sihvonen-Riemenschneider, 
Josten, Wong & Liljestrand, 2010). 
Squamous cell carcinoma: A condition in which cancer begins in the squamous 
cells. Squamous cells are thin, flat cells that look like fish scales, and are found in the 
tissue forming the surface of the skin, the lining of the hollow organs of the body, and the 
lining of the respiratory and digestive tracts (National Cancer Institute, n.d. e). 
Assumptions 
 In this study, I relied on the following assumption: Indigenous Amerindian 
women with HPV will require better access to cytologic cervical cancer screening, easier 
access to well-equipped medical care facilities, and increased awareness and 
understanding of HPV and cervical cancer. 
Limitations 
This research study was limited to existing data collected from the Guyana Cancer 
Registry between 2000 and 2012. Denominator data was not available to calculate 
incidence rates for the sample population. However, I used estimated incidence rates to 
calculate incidence rate ratios in this study. I collected information on Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women age 13 years of 
age and over who were diagnosed with cervical cancer. Age, marital status, geographical 
regions, year of diagnosis, and the stage at diagnosis of cervical cancer were the variables 







I used data from the Guyana Cancer Registry for the Indigenous Amerindian 
women, Afro-Guyanese women, and Indo-Guyanese women. No other cervical cancer 
data were used.  
Significance of the Study 
 Lack of screening programs or ineffective use of these programs in developing 
countries contributes to the increased risk of women developing cervical cancer (Akers, 
Newman & Smith, 2007; Franco et al., 2008; Vaccarella et al., 2013; Winkler et al., 
2008). Failure to implement effective screening and detect, diagnose, and treat cervical 
cancer early could increase the incidence of cervical cancer among women and lessen 
their chance of living longer lives. The significance of my study was to examine age, 
marital status, geographic regions, year of diagnosis, and stage at diagnosis of cervical 
cancer in IAW, AGW, and IGW. Findings from this study could provide more insight for 
public health officials to develop and implement appropriate interventions to address 
cervical cancer among the three groups of women.  
Implications for Social Change 
 The incidence and mortality rates of cervical cancer in Guyana are very high 
(Bruni et al., 2014). Women over 15 years old are vulnerable to getting cervical cancer 
(Bruni et al., 2013). The cervical cancer cases among IAW, AGW, and IGW were 140, 
3140, and 2520 respectively for the study period, 2000 – 2012. A better understanding of 
the epidemiology of cervical cancer among these three ethnic groups would enable the 





social change by raising awareness and knowledge about the importance of early 
detection and screening of cervical cancer among IAW, AGW, and IGW. Early 
recognition of the problem by the government and early implementation of cervical 
cancer prevention programs could have a positive impact in reducing the high incidence 
of and mortality from cervical cancer among these three ethnic groups of women. The 
information provided in this study could also influence how the Guyana government 
responds to cervical cancer health outcomes among Amerindian women living in remote 
and rural areas of the country, as well as for Afro-Guyanese and Indo-Guyanese women 






Chapter 2: Literature Review  
Introduction 
 In this chapter, I discussed the literature on the prevalence of cervical cancer and 
HPV in developing countries. I reviewed the existing literature on the prevalence of 
cervical cancer and HPV among Indigenous Amerindian women in Guyana in order to 
identify gaps in the literature. Understanding the epidemiology of cervical cancer and the 
role of HPV among Indigenous women living in remote and rural areas is important in 
order to design more effective prevention programs. 
 I conducted the literature review using Walden University Library resources to 
access EBSCO, CINAHL, PubMed, ProQuest, and MedLine databases.  I also used 
Google Scholar and publications from the Lancet and the Journal of Obstetrics & 
Gynecology. Key words used in this literature search include cervical cancer, HPV, 
indigenous, Amerindian, human papillomavirus, Guyana, HPV and cervical cancer, 
incidence, and mortality. In this chapter, I first offered a brief overview of the history of 
Guyana. Next, I reviewed relevant literature on cervical cancer epidemiology, the role of 
HPV, types of HPVs and their prevalence in developing countries, and risk factors 
associated with HPV. Finally, I offered a summary of the epidemiological literature on 
the incidence of cervical cancer and HPV infection among Indigenous populations, 
including studies that specifically addressed the incidence of cervical cancer and HPV 







Background of Guyana 
Guyana, the only English-speaking country in South America, has an area of 
215,000 square kilometers and is located on the northeastern coast of South America 
along the borders of Venezuela, Brazil, and Suriname (PAHO, 2013a). Guyana 
progressed from a colony of Britain to an independent country in 1966, and further to a 
republic in 1970, maintaining a democracy (PAHO, 2013a; World Health Organization 
and Ministry of Health Guyana, 2008). In 2010, Guyana’s estimated population was 
785,000 (PAHO, 2013a), and was composed of several ethnic populations with Indo-
Guyanese accounting for 43.5% of the population, Afro- Guyanese 30.2%, Amerindians 
9.2%, and people of mixed heritage 16.7%. People of other descents, including European 
and Chinese, accounted for 0.4% of the population (PAHO, 2013a; PAHO, 2012). 
Included in Guyana’s natural resources are bauxite, gold, diamonds, fertile soil, and water 
resources from its many rivers and vast rainforests which cover almost 80% of its 
territory (PAHO, 2013a; PAHO, 2012). Despite its abundant resources, Guyana remains 
one of the poorest countries in South America and the Caribbean (PAHO, 2012; World 
Health Organization and Ministry of Health Guyana, 2008), and has a gross domestic 
product of 2.85 billion U.S. dollars (The World Bank, 2014). For many years, Guyana 
was rated as a low-income developing and heavily indebted poor country (PAHO, 2013a; 
PAHO, 2012), but today its status has been upgraded to a lower middle-income 
developing country (PAHO, 2013a).  
 Guyana is divided into ten administrative regions. The rural and remote regions 





population lives (PAHO, 2013a; World Health Organization and Ministry of Health 
Guyana, 2008). 85.1% of the population resides in the coastal regions of 2, 3, 4, 5, and 6. 
The capital city, Georgetown, is located in region 4 and accounts for 41.3% of the 
population. Region 10 has a moderate sized town and a large rural area (PAHO, 2013a; 
World Health Organization and Ministry of Health Guyana, 2008). The Indo-Guyanese 
(East Indian) population primarily dwells within regions 2, 3, 5, and 6, the Afro-
Guyanese in region 10, and the Amerindians in regions 1, 8, and 9. Regions 4 and 7 have 
a mixed population (World Health Organization and Ministry of Health Guyana, 2008).  
Guyana experiences many health challenges related to communicable and chronic 
non-communicable diseases. The highest burden of morbidity and mortality is as a result 
of chronic non-communicable diseases among which are cerebrovascular diseases, 
ischemic heart disease, diabetes, hypertension, and cancer (PAHO, 2012). According to 
the PAHO, 60% of all deaths in 2008 were as a result of chronic, noncommunicable 
diseases, with cancer attributing to 20% of these deaths (PAHO, 2013a). Breast, prostate, 
and cervical cancers are the most frequently occurring cancers in Guyana (PAHO, 2012). 
The incidence rate of breast, prostate, and cervical cancer in 2004 was 85, 72 and 
64/100,000 population respectively, as compared to 54, 53, and 27/100,000 population in 
2000 (PAHO, 2012). The incidence rate of cervical cancer in 2004 was more than double 
the incidence rate reported for 2000.  
Biologic Characteristic of Cervical Cancer 
 The American Cancer Society (ACS; 2014b) has reported that most cervical 





precancerous changes before developing into cancer. Cervical cancer occurs at the area of 
the cervical transformation zone, which is a ring of tissue where the squamous epithelium 
joins with the glandular epithelium (Schiffman et al., 2011). The most common types of 
cervical cancer are squamous cell which accounts for more than 70% of cervical cancers, 
and the adenocarcinoma, which makes up approximately 25% of cervical cancers 
(Morrison, Moody & Shelton, 2010). Cervical cancer grows slowly (Morrison et al., 
2010; Schiffman et al., 2011), developing from HPV infection to cervical cancer through 
a series of four distinct steps (Schiffman et al., 2011; Vesco et al., 2011). The first step in 
this process involves HPV transmission, which progresses to acute HPV infection, and 
which is believed to be the primary cause of cervical cancer (Morrison et al., 2010; 
Schiffman et al., 2011). The next step in this cervical carcinogenesis process is persistent 
HPV infection, which leads to the development of cervical precancer and especially 
cervical intraepithelial neoplasia grade 3 (CIN3).This is followed by invasion that results 
in cancer (Schiffman et al., 2011; see Figure 1).  
 
Figure 1. Model showing the progression of cervical cancer. From “Human 
Papillomavirus Testing in the Prevention of Cervical Cancer,” by M. Schiffman, N. 
Wentzensen, S. Wacholder, W. Kinney, J. C. Gage, and P. E. Castle, 2011, Journal of 
National Cancer Institute, 103(5), p. 371. Copyright 2011 by Oxford University press. 
Reprinted with permission. 
 
 
Cervical intraepithelial neoplasia (CIN) also known as the precancerous or 





According to Morrison et al. (2010), HPV infections that persist beyond two years could 
lead to the development of CIN, and if not treated in a timely fashion may result in 
cervical cancer. 
Cervical cancer could go unnoticed because there are usually no noticeable signs 
or symptoms present during the early stages of the disease (National Cancer Institute 
[NCI], 2014). However, during its late stages women may experience signs and 
symptoms such as pelvic pain, pain during sexual intercourse, vaginal bleeding, and 
unusual vaginal discharge, as well as hematuria or rectal bleeding that is secondary to 
tumor invasion through the bladder or rectal wall (Morrison et al., 2010; NCI, 2014). In 
addition, Morrison et al. (2010) noted that other nonspecific signs and symptoms of 
cervical cancer such as unexplained weight loss that is accompanied by nausea, vomiting, 
and loss of appetite should not go unnoticed. Screening for cervical cancer is, therefore, 
important in order to detect and treat the disease in its early stage so as to increase a 
woman’s chance of survival.  
Cervical cancer screening helps to detect precancerous lesions and could prevent 
women from getting cervical cancer (ACS, 2013c). The decrease in the incidence and 
mortality of cervical cancer can be attributed to the overall success of cervical cancer 
screening (Morrison et al., 2010; Saslow et al., 2012). Through cervical cancer screening, 
there has been an increase in the detection of invasive cervical cancer at early stages and 
treatment of pre-invasive lesions (Saslow et al., 2012). Thus, timely diagnosis and 





relative survival rates for cervical cancer patients according to ACS (2013c) are 87% and 
68% respectively.  
For many years, screening has been the preferred method used to detect cervical 
cancer. However, the World Health Organization (WHO) has proposed a “screen-and-
treat” approach to cervical cancer, in addition to screening and diagnosis by means of 
cytology, colposcopy, biopsy, and the histological confirmation of CIN (WHO, 2013b). 
According to the WHO (2013b), the “screen-and-treat” approach involves conducting 
screening tests such as HPV testing, visual inspection with acetic acid (VIA) which is 
carried out by staining the cervix with a 5% solution of vinegar where abnormal cervical 
tissue becomes white after 30 to 60 seconds (CDC, 2015), and cytology (Pap test). The 
treatment approach according to the WHO (2013b) involves using cryotherapy which is a 
technique involving the use of extreme cold to treat tumors (National Cancer Institute, 
2003), large loop excision of the transformation zone (LEEP/LLETZ), and cold knife 
conization. Thus, the “screen-and-treat” approach could be beneficial to healthcare 
professionals in terms of making timely treatment decisions after a positive screening test 
is confirmed (WHO, 2013b). Cervical cancer screening for women who are younger than 
20 years of age is not recommended because of its harmful effects (Vesco et al., 2011). 
However, cervical cancer screening is recommended for women who are at average risk 
of getting cervical cancer and are between the ages of 21 years and 65 years (ACS, 
2013c). Women, on the other hand, who are older than age 65 and who have had 
adequate screening and are not deemed as high risk of getting cervical cancer should not 





Human Papillomavirus Link to Cervical Cancer 
Introduction  
HPV is a non-enveloped, double-stranded DNA virus that is known to cause cell 
abnormalities (Morrison et al., 2010; Nour, 2009). HPV infects the epithelium and 
produces new viral particles only in fully matured epithelial cells (Crosbie et al., 2013; 
Nour, 2009). Once infected, these cells become precancerous and could lead to CIN or 
adenocarcinoma in situ (AIS) (Nour, 2009). The causal link between HPV infection and 
cervical cancer was first discovered by Harald zur Hausen (Nobel Media AB, 2014). 
Based on his findings, zur Hausen concluded that patients infected with HPV types 16 
and 18 were at increased risk of developing cancer (Nour, 2009).  
HPV infection is the most common sexually transmitted infection worldwide and 
is predominantly spread through sexual contact (Nour, 2009; Warman, 2010). Several 
epidemiology studies have established that HPV infection causes cervical cancer (Andall-
Brereton et al., 2011; Correnti et al., 2011; Gudlevičienė, Smilgevičiūtė-Ivshin, 
Vaitkuvienė, Šepetiene, & Didžiapetrienė, 2010; Garland et al., 2011; Mendes de 
Oliveira, Fregnani, Carvalho, Longatto-Filho, & Levi, 2013; Mendoza et al., 2013). In 
addition to being the cause of cervical cancer, HPV is also responsible for causing other 
cancers of the vagina, penis, vulva, anus, head and neck, as well as anogenital warts and 
recurrent respiratory papillomatosis (Bruni et al., 2014; Crosbie et al., 2013; Nour, 2009). 
There are over 100 known types of HPV which are classified as high-risk or low-risk 
depending on their oncogenicity (Morrison et al., 2010; Crosbie et al., 2013; Nour, 2009). 





low-risk types cause low-grade intraepithelial neoplasia or condyloma (Morrison et al., 
2010).  
Epidemiology of HPV Infection 
Prevalence  
The prevalence of HPV infection has been documented worldwide for women 
with normal cytological findings (Bruni, Castellsagué, Ferrer, Bosch and de Sanjosé, 
2010; Crosbie et al., 2013). The HPV virus has been identified in 99.7% of women with 
cervical cancer (Nour, 2009) while HPV types 16 and 18 are the most prevalent types and 
account for approximately 70% of all cervical cancer worldwide (Bruni et al., 2014; 
Crosbie et al., 2013; Li, Franceschi, Howell-Jones, Snijders and Clifford, 2011; Nour, 
2009). Dames et al. (2014) note that high-risk HPV types 16 and 18 account for the 
majority of all invasive cervical cancers (56.5% and 16% respectively) in the world, 
while the other 27.4% of all invasive cervical cancers worldwide are attributed to the 
prevalence of HPV 58, 33, 45, 31, 52, 35, 59, 39, 51, and 56. The largest percentage of 
HPV 16 is found in western-central Asia (73%) and the smallest percentage in Africa 
(53%) (Guan et al., 2012). According to Nour (2009), the prevalence of HPV is highest in 
developing countries, especially Latin America and the Caribbean, sub-Saharan Africa, 
and Southeast Asia. DeMartel et al. (2012) also agree that HPV severely affects 
developing countries, particularly with all cervical cancer which consist of approximately 
530,000 cases per year, and 88% (approximately 24,000 cases) of anal cancers per year. 
 The prevalence of HPV 16 and 18 occurring as the most common type of 





meta-analysis of 1,016,719 women with normal cervical cytology. Results showed an 
estimated global prevalence of 11.7% (95% CI, 11.6%-11.7%) with the highest 
prevalence recorded for sub-Saharan Africa (24%), Eastern Europe (21.4%), and Latin 
America (16.1%). The most common HPV types reported worldwide from this analysis 
were HPV 16 (3.2%), HPV 18 (1.4%), HPV 52 (0.9%), HPV 31 (0.8%), and HPV 58 
(0.7%). It was noted that these HPV types were found mainly in younger women (< 25 
years) while similar observations were made in older women (> 45 years) in Africa and 
the Americas (Bruni et al., 2010).  
Other epidemiological studies have substantiated Bruni et al. (2010) findings as 
mentioned above. A study in Brazil found that HPV 16 (77.6%), HPV 18 (12.3%), HPV 
31 (8.8%), HPV 33 (7.1%) and HPV 35 (5.9%) were the most frequent types found in 
women with invasive cervical cancer (Mendes de Oliveira et al., 2013). In Venezuela, 
HPV 16 and 18 (65%), followed by HPV 52, 33, 45, and 31 were detected in cervical 
carcinoma among women (Correnti et al., 2011). In Colombia, HPV 16 and 31 were the 
most prevalent types among a sample of 2110 women who were tested for the presence 
of HPV-DNA by polymerase chain reaction. The results showed distinct type-specific 
distribution among the regions and a high association between absence of pregnancies, 
indigenous ethnicity, and co-infection (Camargo et al., 2011). Another study on the 
prevalence of infection with high-risk HPV in Colombia, the investigators determined 
that HPV 18, HPV 39, HPV 45, HPV 59 and HPV 68 were associated with multiple 
infections. Of the 49.2% of women confirmed with HPV infection, 59.8% of these were 





ethnicity were statistically significant risk factors for HPV infection (Soto-DeLeon et al., 
2009).  
 In South America and the Caribbean, the high rates of incidence and mortality of 
cervical cancer are complicated by the high prevalence of HPV. Because of lack of data 
on HPV in these countries and inability to track its pathways, HPV prevalence is 
underreported. In South America, 14.4% of women have cervical HPV infection (Bruni 
et al., 2014). In addition, the majority of invasive cervical cancers (72%) are attributed to 
HPV 16 or 18 (Bruni et al., 2014).This latter information is similar to that previously 
mentioned about HPV 16 and 18 being associated with cervical cancer. Many studies 
have thus emphasized the need to conduct further investigation into the epidemiology of 
HPV infections and the role of HPV testing in the screening, prevention, and control of 
cervical cancer (Andall-Brereton et al., 2011; Kightlinger et al., 2010; Lewis-Bell, 2013; 
Watt et al., 2009).  
The prevalence of HPV types 16 and 18 appear to be uniform across countries 
with some variations occurring in other HPV genotypes. Cathro et al. (2009) conducted a 
cervical cancer screening including HPV genotyping among 463 women from the general 
population in Belize where cervical carcinoma is reported to be the most common cancer 
among women. Results of this study found a 15.6% prevalence of high-risk genotypes, 
with HPV types 16, 18, 56, and 52 being the most common types identified among the 
women. HPV 16 and 18 were recognized in women with normal cytology (10.1%), while 





intraepithelial lesion (HSIL). The authors suggested that their findings could augment the 
development and implementation of HPV vaccines in less developed countries. 
In the Caribbean where HPV prevalence is very high, case-controlled studies have 
also linked invasive cervical cancer with HPV 16 and 18. Dames and colleagues (2014) 
carried out a study among HIV-positive women in the Caribbean to evaluate the 
frequency of high-risk HPV genotypes in this population. Participants included 167 non-
pregnant, HIV positive women who were older than 18 years of age. Results reported in 
this study were similar and consistent to other findings from previous studies on HPV 
prevalence where HPV types 16 and 18 were the most commonly diagnosed types. In this 
study, HPV 52 and 58 were the most frequent infections reported. These authors 
recommended further investigation to determine the role of HPV 52 and 58 in the 
development of cervical cytological abnormalities. Another case-control study performed 
in Uganda to assess the risk of invasive cervical carcinoma associated with HIV and HPV 
types also found statistically significant odd ratios among women infected with HPV 16, 
18 and 45 (Odida et al., 2011).  
Not all studies conducted on HPV prevalence and incidence report HPV 16 and 
18 as the most predominant types. Shrestha and colleagues (2010), in their study, 
observed an increased prevalence and incidence of HPV types 58, 53/66, 68/70, and 
31/33/35 in African American, HIV-positive adolescents. This study was carried out to 
examine the effect of highly active antiretroviral therapy (HAART) on the incidence, 





Similarly, Watt and colleagues (2009) discovered a higher prevalence of HPV 
types 45 (2.17%) and 58 (18.8%) in their study to determine the presence of high-risk and 
multiple HPV infections in a population of cancer-free Jamaican women and its 
association with their lifestyle and sexual practices. Other high-risk types found in this 
study included HPV 16 (18.4%), HPV 35 (15.0%), HPV 18 (14.5%), HPV 52 (12.0%), 
and HPV 51 (11.1%). Findings from this study also identified 87.7% of HVP presence in 
this sample population, with pregnant women accounting for the higher prevalence, and 
with the highest prevalence attributed to high-risk HPV and multiple HPV infections. In 
contrast to a later study conducted in Jamaica, Lewis-Bell and colleagues (2013) reported 
a different HPV frequency distribution. The most frequently occurring types were HPV 
16, 35, 62, 83, 61, 58, 84, 18, 66 and 81, with HPV prevalence being highest among 
single women ages 16-19 years old, who had had more than three sexual partners in their 
lifetime. These findings also detected oncogenic HPV in the 297 study participants 
(39.9%) and HPV 16 and 18 in 86 women (10.0%).  
Two other studies conducted in Trinidad and Tobago also showed very high HPV 
prevalence and differences in HPV dominance. In the earlier study to estimate the 
prevalence of cervical HPV infection in a cohort of 310 sexually active women aged 18 
to 65 years with no previous diagnosis of cervical cancer, Andall-Brereton and colleagues 
(2011) sought to determine HPV genotypes and their distribution within the sample. 
These authors observed a high prevalence of HPV within their study participants 
(40.6%), with 60% of infections considered as high-risk. Of the most common high-risk 





(10.3%) occurred more frequently than HPV 16 (9.5%) and HPV 18 (8.6%). This 
frequency was followed by HPV 58 (7.9%). In addition, this study also found an 
association between eleven high-risk genotypes and cytologic abnormalities. Conversely, 
in a later study to determine the relative contribution of known high-risk human 
papillomavirus genotypes to the occurrence of cervical cancers in Trinidad, Hosein, 
Mohammed, Zubach, Legall, & Severini (2013) observed HPV infection in 91.8% of the 
participants. Results showed a strong association between HPV 16 (66.1%) and HPV 18 
(17.8%) with cases of invasive squamous cell carcinoma, followed by HPV 45 (8.9%) 
which is the third most frequent high-risk genotype. Based on these findings, these 
authors concur with other studies that women who have high-risk HPV 16 and 18 
infections, develop cervical cancer at higher rates as compared with those infected with 
other high-risk HPV types or with low-risk types (Hosein et al., 2013; Rocha, Filho, de 
Queiroz and dos Santos, 2013).  
HVP Prevalence in Indigenous Populations 
 Other studies conducted in indigenous populations also reveal a high prevalence 
of HPV infection with high-risk types. In a cross-sectional study, Mendoza et al. (2013) 
analyzed the frequency of HPV and other genital infections among indigenous women 
from Paraguay. 181 sexually active women without cervical lesions participated in the 
study. Results showed that HPV infection was the most frequent, with any-type HPV of 
23.2% (n = 42; 95% CI: 17.3-30.0) and 16.1% of women positive for high-risk HPV 
types (n=29; 95% CI: 11.1-22.3). There was also a significant association observed 





this study was higher than the 13.2% (95% CI: 12.7-13.7) prevalence reported by Bruni 
et al. (2010) in the meta-analysis involving 17,500 urban women from South America 
who had normal cytology.  
 In another study to determine the prevalence of cervical disease, human 
papillomavirus infection, and human papillomavirus genotypes in indigenous villages of 
Guyana, Kightlinger et al., (2010) found invasive cervical carcinoma in 0.80% of the 
women, cervical intraepithelial neoplasia II and III in 5.07% of the women, and a high-
risk HPV infection rate in 19.3% of the women. Sixteen genotypes were detected in 
women with high-grade dysplasia or cancer with HPV 31 (25.0%), HPV 16 (22.7%) and 
HPV 18 (13.6%) being the most common HPV types. The rate of HPV 16 and 18 in 
cervical cancer was 55.50%. Based on these findings, Kightlinger and colleagues (2010) 
concluded that Indigenous Guyanese women have a high rate of cervical cancer and high-
grade dysplasia with HPV 16 and 18 being the leading cause of invasive cancer. These 
findings are not consistent with results from other studies which showed that other HPV 
types are more dominant than HPV 16 or 18 (Shrestha et al., 2010; Watt et al., 2009; 
Andall-Brereton et al., 2011).  
 In a quantitative study of Indigenous women in the Amazon region of Brazil, 
Rocha et al. (2013) found a high prevalence of HPV 16 (58.1%) and HPV 58 (20.0%) in 
their sample involving 361 sexually active women over 18 years of age. In addition, 13 
more types of HPVs were detected, namely, HPV 33, 81, 6, 70, 31, 35, 45, 52, 53, 61, 68, 
71, and 89. HPV 58 is considered the seventh most common type with precursor lesions 





cytological abnormalities (Rocha et al., 2013). According to Rocha and colleagues 
(2013), the prevalence rates of HPV 58 in other countries show marked differences exist 
between regions, especially in Latin America and Asia which account for the highest 
prevalence rate of this type of HPV. Additionally, other studies conducted in Brazil on 
the prevalence of HPV also established that HPV 16 is the most frequently common 
infection in women (Castro, Farias, Borborema-Santos, Correia, & Astolfi-Filho, 2011; 
Mendes de Oliveira et al., 2013).  
 Consistent with the high-risk of HPV in Indigenous populations in Central and 
South America and the Caribbean, a high prevalence of HPV has also been found among 
Indigenous women in North America. Women living in the Appalachian region of the 
United States experience severe cancer disparities and have the highest incidence and 
mortality rates of cervical cancer in the U.S. (Reiter et al., 2013). In examining the 
prevalence of genital HPV among 1116 Appalachian women in their case-control study, 
Reiter et al. (2013) detected a high prevalence of HPV among them. The prevalence of 
any HPV type in this sample was 43.1%, followed by 33.5% of high-risk HPV types, 
23.4% of low-risk types, and 12.5% for vaccine-preventable HPV types. Younger age 
(18-26 years; OR = 2.09, 95% CI: 1.26-3.50), current smokers (OR = 1.86, 95% CI: 1.26-
2.73), number of male sexual partners (at least five) during lifetime (OR = 2.28, 95% CI: 
1.56-3.33), and multiple male sexual partners during the last year (OR = 1.98, 95% CI: 
1.25-3.14) were associated with contracting HPV infection. Because of a deficiency of 





their findings could provide pertinent information relative to cervical cancer screening 
and prevention within the Appalachian region. 
 In another case controlled study among Indigenous and non-Indigenous 
Australian women to determine differences in the prevalence of HPV type by area of 
residence or ethnicity, Garland and colleagues (2011) reported that Indigenous women 
were at a higher risk of HPV prevalence especially from risk factors associated with it. 
Although HPV 16 and 18 was similar for both groups (HPV 16 was 9.4% and 10.5% 
respectively; and HPV 18 was 4.1% and 3.8% respectively) and not associated with place 
of residence, there was a significant difference in the prevalence of HPV 68 for both 
Indigenous and non-Indigenous women (OR = 3.8, 95% CI 1.9 to 7.5%; p < 0.001). HPV 
16 was the most common genotype detected in both groups of women, followed by types 
51, 52, 18 and 39. Age was a factor associated with the higher prevalence of HPV for 
Indigenous women, particularly in the 31 to 40 years age group category (35% versus 
22.5%; p < 0.001) even though no association was observed in younger women on the 
prevalence of high-risk types. These authors, like others mentioned before, emphasize the 
importance of cervical cancer screening and obtaining data on HPV genotype prevalence 
to better target women who are at high risk of getting HPV infection and cervical cancer.  
 In Canada, Indigenous women residing in the Aboriginal populations reportedly 
have higher rates of cervical cancer than other Canadian women (Brassard et al., 2012). 
Geographic and ethnic variations in HPV prevalence exist among regions in Canada 
(Jiang et al. (2013). Studies conducted in the Northwest Territories of Canada report 





associated with it (Brassard et al., 2012; Jiang et al., 2013; Jiang et al., 2011). In 
examining 5725 bio-samples to determine the prevalence of HPV infection on different 
virus types and their association with cervical dysplasia in the Northwest Territories of 
Canada, Jiang and colleagues (2011) reported a high prevalence of high-risk HPV in 
these regions, especially among Aboriginal women whose prevalence rate was 
approximately 50% more than non-Aboriginal women. The overall HPV prevalence 
reported in the sample was 24.2%. 89.5% of the cervical dysplasia cases were from HPV 
infection, and HPV 16 or 18 was responsible for 21.7% of the cases. Analysis of the 
HPV-positive samples also showed that 76.6% of the women harbored high-risk types, 
35.2% had multi-type infections and 21.6% had HPV 16 or 18 infections.  
 Results of a later study by Jiang and colleagues (2013) to examine the prevalence 
of HPV infections and their association of different types with cervical dysplasia among 
women in Northern Canada, also showed that Aboriginal women had a higher prevalence 
rate of HPV infection (approximately 50%) than the non-Aboriginal population (27.6 vs. 
18.5%). These results were similar to the one previously reported by Jiang and colleagues 
(2011) who also found a higher prevalence rate of HPV infection in Aboriginal women 
(approximately 50% higher) as compared to the non-Aboriginal population. Granted that 
HPV 16 was the most common type detected across the region, Jiang and colleagues 
(2013) reported no difference of HPV 16 or 18 infections among Aboriginal women and 
non-Aboriginal women. Younger age (<20 years) was a determining factor in the highest 





Brassard et al. (2012) also support the findings of Jiang et al. (2011 and 2013) that 
Aboriginal women were more affected by high-risk HPVs than non-Aboriginal women. 
Determinants of high-risk HPVs found in this sample were younger age, single marital 
status, aboriginal background, current smoking, lifetime deliveries, use of hormonal 
contraceptives, and numbers of sexual partners in the previous year. These findings were 
also consistent with those reported by Demers et al. (2012b).  
Risk Factors for HPV 
Persistent infection with certain HPVs causes cervical cancer (ACS, 2013c). Lack 
of knowledge and awareness could be detrimental to women’s health. Therefore, 
identifying the risk factors associated with cervical cancer is extremely important. Even 
though numerous epidemiological studies have identified certain risk factors as 
contributing to the development of cervical cancer, HPV infection is considered the most 
important factor in this process. An increased risk of HPV infection is linked to sexual 
behaviors such as first sexual intercourse at an early age, multiple sex partners, and the 
indiscriminate sexual behavior of the partner (Morrison et al., 2010; Louie et al., 2009; 
Warman, 2010). Age at first sexual intercourse and age at first pregnancy are significant 
risk factors for cervical cancer (Louie et al., 2009). In their pooled case-control studies on 
invasive cervical cancer from eight developing countries, Louie and colleagues (2009) 
reported a 2.4 fold risk among women, who were less than 16 years of age, and who 
initiated their first sexual intercourse, and who experienced their first pregnancy when 
compared to women who were over 21 years. In another study, age, ethnicity, and the 





HPV infection (Demers et al., 2012b). This study examined a sample of 592 women to 
determine risk factors associated with HPV infections and to link the HPV types with the 
cervical cancer screening history of their participants. HPV infection was detected in 115 
participants (19.4%), 89 of whom had a normal Pap test. HPV 16 was the most prevalent 
type found in this study (15/115: 13.0% of infections). Of the women who were HPV 
positive, 10.3% (61) had high-risk HPV. 
Several other factors are thought to be associated with persistence of HPV 
infection and progression to cervical cancer. These include history of sexually transmitted 
diseases, number of child births, long-term use of oral contraceptives, smoking, 
immunodeficiency, exposure to HIV, low socioeconomic status, and lack of access to 
health (ACS, 2013c; Morrison et al., 2010; Carmargo et al., 2011; Gudlevičienė et al., 
2010; Muñoz & Bravo, 2012; Warman, 2010). Carmargo and colleagues (2011) found 
that early initiation of sexual intercourse and uses of oral contraceptives put women at 
increased risk of HPV infection. These authors note that women without any history of 
previous pregnancies were at a greater risk of HPV infection than women who had more 
than four full-term pregnancies because of their likelihood to engage in risky sexual 
practices. In another study, statistically significant associations were found between high 
parity (p = 0.04), rural residence (p = 0.03), low socioeconomic status (p = 0.01) and 
illiteracy (p = 0.07) and high-risk HPV infection among a population of 769 cytologically 
negative women, aged 18-45 years (Gupta et al., 2009). Still, in their case controlled 
study to detect HPV, its type prevalence, and other risk factors associated with cervical 





colleagues (2010) reported that socioeconomic status and the sexual history of women 
were the most important risk factors for the development of cervical cancer. In addition 
to these risk factors, smoking was considered a likely determinant for HPV infection. The 
odds ratio adjusted by the age showed that women who smoked were two times more 
likely to be at risk for cervical cancer than those who did not smoke (OR = 2.0, 95% CI 
1.2-3.5). This result differed however, after the odds ratio adjustment by age and HPV 
positivity, where smoking did not increase the risk of cervical cancer. Similar results 
found by Garland and colleagues (2011) showed that smoking was strongly associated 
with any HPV type among Indigenous women who were twice as likely to smoke (45.9% 
versus 21.8%, p < 0.001). The result from this study also showed that Pap-test 
abnormalities and younger age especially among Indigenous women were associated with 
the risk for cervical cancer. Women were seven times as likely to have a current high-
grade Pap test result (3.1% versus 0.4%, p = 0.03), or to have their first ever Pap test (n = 
3 (3.2%) versus n = 1 (0.4%), p = 0.03).  
Epidemiology of Cervical Cancer 
Worldwide, cervical cancer ranks as the third most common cancer in women 
(Arbyn et al., 2011; Colantonio et al., 2009; Jemal, Center, DeSantis & Ward, 2010; 
Muñoz & Bravo, 2012; Oh et al., 2013; Pierce Campbell, Curado, Harlow & Soliman, 
2012; Vaccarella et al., 2013) and is the fourth leading cause of death in women 
(International Agency for Research on Cancer (IARC), 2013; Jemal et al., 2011; Jemal et 
al., 2010). In 2012, worldwide statistics showed there were 266,000 deaths from cervical 





under-developed countries (IARC, 2013). Very high rates of cervical cancer incidence 
exist in India where more than one fifth of all new cases are diagnosed (IARC, 2013). In 
addition, sub-Sahara Africa also has high incidences of cervical cancer with 34.8 new 
cases being diagnosed annually per 100,000 women, and 22.5 deaths per 100,000 
annually (IARC, 2013). When these incidence and mortality rates are compared with 
those of North America (6.6 per 100,000 women and 2.5 per 100,000 women 
respectively), the lower rates in North America highlight the grim reality of the burden of 
cervical cancer in developing countries.  
In developing countries, cervical cancer ranks as the second most common 
cancer, with 452,000 cases reported for these regions in comparison to developed 
countries where cervical cancer is ranked as the 10th most common cancer with 76,000 
reported cases (Ferlay et al., 2010; Munoz & Bravo, 2012). In 2008, the worldwide 
estimate of cervical cancer revealed there were 530,000 (9%) new cases and 275,000 
(8%) deaths (ACS, 2011; Arbyn et al., 2011; Jemal et al., 2011; Muñoz & Bravo, 2012; 
Pierce Campbell et al., 2012; Vaccarella et al., 2013), with approximately 88% of these 
deaths occurring in developing countries (Jemal et al., 2011; Ferlay et al., 2010).  
The marked differences in the morbidity and mortality rates associated with 
cervical cancer in developed and developing countries are significant. The reported 
mortality in 2008 for Asia was 159,800; followed by 53,000 in Africa and 31,400 in Latin 
America and the Caribbean (Ferlay et al., 2010). In 2008, the reported age-standardized 
incidence rates (ASIR) and age-standardized mortality rates (ASMR) were two to three 





example, the ASIR for developing countries was 18/100,000 compared to 9/100,000 for 
more developed countries, while the ASMR for developing countries was 10/100,000 in 
contrast to an ASMR of 3/100,000 for developed countries (Arbyn et al., 2011). In 
addition, in 2008, 1.9% of women developed cervical cancer and 1.1% died of the disease 
before reaching the age of 75 in developing countries (Arbyn et al., 2011). Worldwide, 
there is a big difference in the incidence and mortality of cervical cancer especially in the 
subcontinents. The highest incidence and mortality rates are reported in Eastern Africa 
(ASIR = 34.5/100,000 and ASMR = 25.3/100,000), Western Africa ((ASIR = 
33.7/100,000 and ASMR = 24.0/100,000), and Southern Africa (ASIR = 26.8/100,000 
and ASMR = 14.8/100,000), followed by South-Central Asia (ASIR = 24.5/100,000 and 
ASMR = 14.0/100,000) and South America (ASIR = 24.1/100,000 and ASMR = 
10.8/100,000) (Arbyn et al., 2011; Jemal et al., 2011). On the other hand, countries such 
as Australia/New Zealand (ASIR = 5.0/100,000 and ASMR = 1.4/100,000), North 
America ((ASIR = 5.7/100,000 and ASMR = 1.7/100,000), and in Western Europe (ASIR 
= 6.9/100,000 and ASMR = 2.0/100,000) have experienced the lowest incidence and 













Figure 2. Age-standardized cervical cancer incidence and mortality rates by world area. 
Adapted from “Global Cancer Statistics,” by A. Jemal, F. Bray, M. M. Center, J. Ferlay, 
E. Ward, and D. Forman, 2011, Cancer Journal for Clinicians, 61(2), p. 80. 
 
The rising number of cases and deaths resulting from cervical cancer is 
perturbing, especially in developing countries. According to Forouzanfar et al. (2011), 
globally, the number of cervical cancer cases has increased by 0.6% annually and the 
number of deaths by 0.46% as a result of population sizes and population ageing. In 
2010, the incidence rates of cervical cancer rose to 454,000 (318,000-620,000) cases per 
year as compared to 378,000 (256,000-489,000) cases per year in 1980 (Forouzanfar et 
al., 2011). Although there has been a decrease in cervical cancer deaths in nearly all 
countries between 1980 and 2010 (Forouzanfar et al., 2011), this disease however, 
continues to have an overall devastating effect. In 2010, cervical cancer death rates were 
reported at 200,000 (139,000-276,000). Of this number, 46,000 (33,000-64,000) women 




































































The heterogeneity in cervical cancer mortality is evident between various countries. 
Malawi, 3.2(1.9-4.8), Ethiopia, 2.9(1.4-7.3), and Guyana, 3.0(2.0-4.3) had high mortality 
risks reported in 2010, while low mortality rates were reported for some countries in 
eastern and southern Africa, and some Latin American countries such as Mexico, Chile, 
and Panama who previously experienced high mortality rates between 1980 and 2010 
(Forouzanfar et al., 2011).  
Cervical Cancer Incidence in Developing Countries 
Latin America 
The incidence of cervical cancer and mortality in developing countries has far-
reaching effects on its population. According to WHO/ICO HPV Information Centre 
(2010), 86% of the cervical cancer cases occur in developing countries. Several studies 
have highlighted the high rates of cervical cancer occurring in Latin American countries 
from Central and South America, and the Caribbean, as well as in sub-Saharan Africa, 
and Southern Asia (Correnti et al., 2011; Jemal et al., 2011; Pierce Campbell et al., 2012; 
Villa, 2012). Disparities in access to cervical cancer screening and treatment, and 
inadequate health care infrastructure are primarily responsible for the high burden of 
cervical cancer within developing countries (IARC, 2013; Jemal et al., 2011; Villa 2012). 
In Latin America and Caribbean countries, this high burden of cervical cancer 
disproportionately affects women (Luciani, Cabanes, Prieto-Lara & Gawryszewski, 
2013). Research has shown that geographic variation plays a role in these disparities 
(Pierce Campbell et al., 2012; Villa 2012). Studies conducted in Latin America and the 





to high (Pierce Campbell 2012; Villa, 2012), from 20 to 80 per 100,000 women per year 
(Villa, 2012). In a study to examine the variation in cervical cancer incidence across 
Latin America and the Caribbean on invasive cervical cancers diagnosed from 1998-
2002, results showed that variations in age-standardized incidence rates varied across 
countries, from a low incidence of 14.6 to a high incidence of 44.0 (Pierce Campbell et 
al., 2012). The age-standardized incidence rates were: Cuba (14.6/100,000); Argentina 
(16.0/100,000); Costa Rico (18.9/100,000); Ecuador (20.0/100,000); Colombia 
927.9/100,000); Brazil (37.7/100,000), and Peru (44.0/100,000). Other findings on the 
variations of cervical cancer incidence in Latin America were also reported by the World 
Health Organization (Villa, 2012) where the highest incidence rates of cervical cancer 
were observed in Haiti (87/100,000), Bolivia (55/100,000), Peru (48/100,000), and 
Nicaragua (47/100,000), while the lowest incidence rates were in Argentina (23/100,000) 
and Uruguay (19/100,000).  
In addition, Luciani et al. (2013) also reported on the differences of cervical 
cancer mortality rates in Latin America and North America. In a study to assess the 
burden of breast and cervical cancers in the Americas, these authors reviewed and 
analyzed mortality data from the PAHO Regional Mortality Database on both breast and 
cervical cancers in 33 countries from 2000-2009 and found that relatively high rates of 
death from breast cancer were found in the Bahamas, Trinidad and Tobago and Uruguay 
while El Salvador, Nicaragua and Paraguay had the highest rates of cervical cancer death, 
17.9, 19.4 and 20.5 deaths per 100,000 females respectively as compared to Canada, 





deaths per 100,000 females, respectively (see Table 1 for mortality data on cervical 
cancer).  
Findings from the above-mentioned studies are significant in terms of gaining a 
better understanding of cancer distribution and the disparities women with cervical 
cancer face in poor countries. Increasing awareness and knowledge of risks across 
geographic areas could provide region-specific recommendations on cancer control and 





Table 1  




Country or territory 




































-2.21(3.31 to -1.09) 
-1.18(-1.52 to -0.83) 








































-7.43 (-12.89 to -16.3) 
-6.65 (-8.44 to -4.82) 
-3.01 (-4.01 to -2.0) 
-4.86 (-5.17 to -4.56) 
-3.73 (-4.76 to -2.68) 




   Colombia 2416 14.7 2008 2609 12.0 -3.05 (-3.54 to -2.56) 
   Ecuador 694 13.9 2009 885 13.3 -0.86 (-1.63 to -0.08) 
   Peru 2117 20.9 2007 2031 16.3 -1.15 (-1.85 to -0.44) 
   Venezuela 1548 15.9 2007 1856 14.9 -1.31 (-2.02 to -0.06) 
Brazil 7965 10.1 2009 8920 8.4 -2.2 (-2.43 to -1.97) 
Southern Cone 
   Argentina 
   Chile 






















-0.99 (-1.48 to -0.49) 
-4.02 (-4.91 to -3.12) 
-3.49 (-4.35 to -2.63) 
Caribbean 
Cuba 531 7.2 2009 593 7.0 -0.16 (-1.18 to 0.87) 
Guyana 72 22.8 2006 44 12.7 -4.88 (-9.77 to 0.27) 
Puerto Rico 94 3.5 2007 106 3.4 -1.79 (-4.65 to 1.16) 
Suriname 26 12.6 2007 21 8.3 -4.77 (-10.37 to 1.17) 
Trinidad and 
Tobago 
89 13.6 2007 95 12.9 -1.59 (-4.80 to 1.73) 
Note. PC, annual percentage change; ASMR, age-standardized mortality rate; CI, confidence interval 
a Deaths per 100,000 females. b Latest year for which relevant data on mortality from cervical cancer were 
available; c In ASMR between 2000 and the latest year for which data were available. Adapted from 
“Cervical and female breast cancers in the Americas: current situation and opportunities for action,” by S. 
Luciani, A. Cabanes, E. Prieto-Lara, and V. Gawryszewski, 2013, Bulletin of the World Health 







 The existence of the high incidence and mortality rates of cervical cancer in other 
developing countries has also been confirmed in the literature (Camargo, 2011; Correnti 
et al., 2011; Luciani et al., 2013; Muñoz & Bravo, 2010; Paz-Soldán, Hayer, Nussbaum 
& Cabrera, 2012). In Peru, cervical cancer ranks as the most common cancer and is the 
second cause of cancer-related deaths among women (Paz-Soldán et al., 2012). 
According to Paz-Soldán et al. (2012), the age-standardized incidence (34.5 per 100,000 
women) and cause-specific mortality (16.3 per 100,000) rates from cervical cancer for 
Peru in 2008 were more than double the rates reported for the Americas. In addition, 
Correnti et al. (2011) reported that women in Venezuela also experience very high 
incidences of cervical cancer where it is the second most common cancer among women 
after breast cancer. According to Correnti and colleagues (2011), the age-standardized 
incidence of cervical cancer in 2008 for Venezuela was 31.4 per 100,000 women and the 
age-standardized mortality rate was 14.4 cases per 100,000 women. This mortality rate 
reflects a decrease from that reported in 2007 (14.9 per 100,000 women) (Luciani et al., 
2013) {see Table1}. Overall, the rates for those countries mentioned above are 
considerably substantial when compared to those previously mentioned for Canada, 
Puerto Rico, and the United States (2.4, 3.4 and 3.1 deaths per 100,000 females, 
respectively).  
Other Latin American countries such as Colombia, Mexico and Brazil also suffer 
from high incidences and mortalities of cervical cancer (Camargo et al., 2011; Luciani et 
al., 2013; Muñoz & Bravo, 2012). However, mortality rates are intermediate among those 





Paraguay as previously mentioned. In Colombia, cervical cancer is the first cause of 
mortality and the second cause of cancer incidence among women (Muñoz & Bravo, 
2012). Based on the GLOBOCAN 2008 estimates reported by Muñoz & Bravo (2012), 
there were 2,154 deaths and 4,736 cases that occurred in Colombia in 2008 (age-adjusted 
incidence rate of 21.5 per 100,000 and a mortality rate of 10.0 per 100,000) with the 
highest mortality rates occurring in poorer regions. Mexico’s mortality rate from cervical 
cancer in 2009 was 8.0 deaths per 100,000 women, while Brazil’s mortality rate was 8.4 
deaths per 100,000 women (Luciana et al., 2013).  
South America and the Caribbean 
Like other countries in Latin America, the Caribbean countries are also seriously 
affected by the high incidence and mortality of cervical cancer. In the Caribbean, 
incidence and mortality of cervical cancer is considered the second most common cancer 
among women of all ages (PAHO/WHO, 2013b). Data on the incidence of cervical 
cancer in non-Latin Caribbean countries are scarce (PAHO/WHO, 2013b); therefore, 
information reported on the incidence and mortality rates might be more than what are 
being conveyed. However, an analysis conducted on the incidence and mortality of 
cervical cancer and HPV prevalence in non-Latin Caribbean countries for three different 
periods (2000-2002; 2003-2003; and 2006-2008) reveal that differences exist in the 
incidence and mortality rates. Incidence rates are highest in the Bahamas (60/100,000), 
Belize (54.9/100,000), Jamaica (17.4/100,000) and Trinidad and Tobago (16.5/100,000); 
and lowest in Bermuda (5.8/100,000) and Suriname (12/100,000 in the urban population 





Table 2  
Summary of Cervical Cancer Incidence Data from non-Latin Caribbean Countries 
 
 
Country (reference)  
 
Year(s) 
Number of new 




 (age group) 
 








1988 – 2002 
58 
(27 – 77 years) 
60/100,000 




(21 – 55 years) 
54.9/100,000 
(21 to 55 years) 
 












Dominica (survey) 2007 – 2011 81 






Jamaica (Kingston & St. 
Andrews area) 
2000 – 2007 
 
 
2003 – 2007 
573 







(20 – 85+ years) 






1980 – 2004 1138 
(all ages) 




Trinidad and Tobago 2000 – 2002 324 
(25 – 85+ years) 
16.5/100,000 
(25 – 85+ years) 
 
Note: Adapted from “Situational analysis of cervical cancer prevention and control in the Caribbean,” by 
Pan American Health Organization/World Health Organization, 2013b, p 11.  
 
Mortality rates from cervical cancer also vary considerably within these 





rates were highest in Belize (25.4/100,000; 20.5/100,000), St. Lucia (34.2/100,000; 
34.6/100,000), and St. Vincent and the Grenadines (30.0/100,000; 20.2/100,000), as well 
as in Dominica from 2003-2005 (23.6/100,000). However, for the periods 2006-2008, 
Dominica, Guyana and St. Vincent and the Grenadines had the highest rates 
(21.7/100,000; 19.0/100,000 and 19.4/100,000 respectively). Overall, Bermuda had the 
lowest rates for all three periods, 2000-2002, 2003-2005 and 2006-2008 (see Table 3). 
Table 3  








Cervical cancer mortality among women aged 15 years and older 
 
 
2000 - 2002 
 
2003 – 2005 
 
2006 - 2008 
 
 No. ASMR No. ASMR No. ASMR 
Antigua and Barbuda 6 7.6 10 11.6 9 9.3 
Aruba 14 10.7 a12 a12.4 12 7.2 
Bahamas 44 14.5 b14 b13.8 33 8.9 
Barbados 56 16.2 c34 c12.8 31 7.3 
Belize 39 25.4 35 20.5 35 17.0 
Bermuda 5 4.7 d1 d3.2 4 2.8 
Dominica n/a n/a 14 23.6 17 21.7 
Grenada 8 11.0 e8 e9.6 18 17.7 
Guyana 108 19.5 112 20.8 107 19.0 
St. Kitts and Nevis 4 8.4 6 10.0 4 7.4 
St. Lucia 52 34.2 56 34.6 f10 f12.5 
St. Vincent and the Grenadines 27 30.0 22 20.2 21 19.4 
Suriname 70 16.3 76 16.7 89 17.7 
Trinidad and Tobago 181 13.6 201 14.0 216 14.1 
 
Note: a. Aruba is missing data for 2005; b. Bahamas is missing data for 2004-2005; c. Barbados is missing 
data for 2003 and for 2005; e. Grenada is missing data for 2005; f. St. Lucia is missing data for 2006-2007. 
Adapted from “Situational analysis of cervical cancer prevention and control in the Caribbean,” by Pan 








Cervical Cancer in Guyana 
The focus of this study was to estimate the incidence of cervical cancer among 
IAW, AGW, and IGW in Guyana. In Guyana, cervical cancer is the second cause of 
female cancer among women and the first most common cancer in women aged 15 to 44 
years (Bruni et al., 2014). According to Bruni et al. (2014), there are 0.26 million women 
aged 15 years and older in Guyana who are at risk of developing cervical cancer. The 
incidence and mortality rates of cervical cancer in Guyana are excessive. Based on the 
2013 estimates of the incidence of cervical cancer as reported by Bruni et al. (2014), 161 
new cases of cervical cancer are diagnosed annually in Guyana with women between the 
ages of 40-64 years accounting for most of these cases. The current age-standardized 
incidence rate for cervical cancer is 46.9 per 100,000 women per year (see Table 4). This 
rate was similar to the age-standardized incidence rate for Brazil (47.7 per 100,000 
women per year) (Bruni et al., 2014). Correspondingly, cervical cancer death in Guyana 
ranks as the first cause of female deaths and the first leading cause of cancer deaths in 
women aged 15 to 44 years (Bruni et al., 2014). There are 71 new cervical deaths that 
occur annually in Guyana; the current age-standardized mortality rate being 21.9 per 
100,000 women per year. Comparing this statistic to the age-standardized mortality rate 
in 2006 (12.7 per 100,000; 95% CI: -4.88 {9.77 to 0.27}), the rate has almost doubled 
within a seven year span. These statistics are nevertheless grim, and they especially stand 
out against the current age-standardized mortality rates for South America (8.6 per 






Table 4  
Incidence of Cervical Cancer in Guyana 
 
Indicator Guyana South America World 
Annual number of new cancer cases 161 45,008 527,624 
Crude incidence ratea 42.7 22.2 15.1 
Age-standardized incidence ratea 46.9 20.3 14.0 
Cumulative risk (%) at 75 years oldb 4.9 2.0 1.4 
 
Note. a Rates per 100,000 women per year; b Cumulative risk (incidence) is the probability or risk of 
individuals getting from the disease during ages 0-74 years.  Adapted from “Human papillomavirus and 
related diseases in Guyana, Summary Report, “ by L. Bruni, L. Barrionuevo-Rosas, G. Albero, M. Aldea, 
B. Serrano, S. Valencia,…X. Castellsagué, 2014, ICO Information Centre on HPV and Cancer (HPV 
Information Centre), p. 6.  
 
Table 5  
Cervical Cancer Mortality in Guyana 
 
Indicator Guyana South America World 
Annual number of deaths 71 19,374 265,653 
Crude mortality ratea 18.8 9.5 7.6 
Age-standardized mortality ratea 21.9 8.6 6.8 
Cumulative risk (%) at 75 years oldb 2.5 0.9 0.8 
 
Note: aRates per 100,000 women per year, bCumulative risk (mortality) is the probability or risk of 
individuals dying from the disease during ages 0-74 years. For cancer, it is expressed as the % of new born 
children who would be expected to die from a particular cancer before the age of 75 if they had the rates of 
cancer observed in the period in the absence of competing causes. Adapted from “Human papillomavirus 
and related diseases in Guyana. Summary Report, “ by L. Bruni, L. Barrionuevo-Rosas, G. Albero, M. 
Aldea, B. Serrano, S. Valencia,…X. Castellsagué, 2014, ICO Information Centre on HPV and Cancer 







Literature Review on Indigenous Populations 
 Several studies have used a quantitative approach to assess the incidence of 
cervical cancer among Indigenous people. A study by the National Aboriginal Health 
Organization with First Nations people across Canada conducted a survey to measure the 
use of preventive health services (Demers et al., 2012a). Results showed similarity in 
rates of screening for cervical cancer between Aboriginal women (71.9%) and non-
Aboriginal women (74.8%) within small communities in the Northwest Territories, but 
differences in another community where Aboriginal women had lower screening rates 
(71.7%) than non-Aboriginal women (92.0%). In Canada, the incidence and mortality 
rates of invasive cervical cancer among Aboriginal women are higher than for other 
groups (Demers et al., 2012a). Incidence rates for invasive cervical cancer for Aboriginal 
women are reportedly 1.7 to 3.5 times higher than the rates for non-Aboriginal women 
while mortality rates are 4 to 5 times higher for these women than for non-Aboriginal 
women (Demers et al., 2012a). Based on the findings, these authors recommended 
developing culturally appropriate educational materials and services related to sexual 
health, screening for cervical cancer and immunization against HPV. Added to these 
recommendations is the need for research to be done on HPV and related outcomes 
among the Aboriginal populations to assess the gaps in knowledge.  
In Latin American, data on cervical cancer among Indigenous people is lacking 
(Goss et al., 2013; Moore et al., 2014). Moore and colleagues (2014) conducted a 





cancer registries from 1980 to assess the cancer epidemiology among Indigenous people 
in Latin American countries of Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, and 
Peru. Results determined that Indigenous people had higher rates of cervical cancer in 
some parts of Brazil, Ecuador, and Guyana; higher stomach cancer rates in regions of 
Chile, and higher gallbladder rates in Chile and Bolivia. Based on the findings, the 
authors stressed the importance of obtaining cancer profiles as well as identifying and 
prioritizing cancer control measures for indigenous people.  
 In another study, Kightlinger and colleagues (2010) conducted a retrospective 
study in Guyana to determine the prevalence of cervical cancer disease and HPV among 
women who live in the indigenous villages. 2250 Amerindian women who participated in 
the study were screened for cervical cancer and HPV. Results showed that Indigenous 
Guyanese women, especially between the ages of 20-30 years, have a high prevalence of 
cervical cancer and high-grade dysplasia, and HPV infection. Based on the findings, the 
authors recommended ongoing HPV genotype analysis in women with high-grade 
neoplasia and cancer, as well as ongoing clinical care and epidemiologic studies in the 
indigenous villages.  
Similar findings on the high incidence of cervical cancer in IAW were also 
reported in another study. Best Plummer et al. (2009) conducted a review of the Guyana 
Cancer Registry’s database, focusing on the ethnic and site prevalence of breast, cervical, 
and prostate cancers. Results showed that the majority of cervical cancers cases were 
found among AGW (39%) but when the proportion of cervical cancer cases for all cancer 





IAW (p<0.0001). These authors recommended further investigation into the high 
incidence of cervical cancer to be carried out. 
Another study using a cancer registry was conducted by Roue and colleagues 
(2012) to determine the incidence rate of cervical cancer in French Guiana. Data on 
cervical cancer between 2003 and 2005 were analyzed. The results indicated that women 
from rural areas had a significantly greater amount of lesions than women from urban 
areas (age-standardized rate of invasive cervical cancer was 30.3 per 100,000 women, 
95% CI, 22.8-37.9). The incidence of invasive cervical cancer increased from age 25 
years then showed a decline after 64 years. Roue and colleagues (2012) recommended 
more organized screening for women in the rural parts of French Guiana. 
 Shannon, Franco, Powles, Leng & Pashayan (2011) evaluated data to determine 
the difference in occurrence and case fatality of cervical cancer among Indigenous and 
non-Indigenous Australian women. Surveillance data was collected from the Australian 
Bureau of Statistics, Australian Institute of Health and Welfare, and State- or Territory-
based Cancer Registries. Results showed that age-standardized incidence rates among 
Indigenous women (16.9 per 100,000 women) was higher than non-Indigenous women 
(7.1 per 100,000 women), and the age-standardized mortality rate was more than 5 times 
the rate for non-Indigenous population (9.9 per 100,000 women years; 95% CI 7.1-13.3). 
Based on these findings, these authors pointed out those Indigenous women were more 
likely to develop cervical cancer and have less survival rates than non-Indigenous 
women. They also conceded that the pattern of cervical cancer incidence and survival 





 Consistent with the above-mentioned findings, Vasilevska, Ross, Gesink, & 
Fisman (2012) conducted a systematic review and meta-analysis on both Indigenous and 
non Indigenous populations to identify whether Indigenous women in Australia, Canada, 
New Zealand, and the United States had higher risks of cervical dysplasia, cervical 
cancer, and cervical cancer-related mortality than the non-Indigenous population. Studies 
published in 1969-2008 were used. Results showed that Indigenous women have a 
significantly higher risk of cervical cancer morbidity (pooled RR=1.72) and mortality 
(pooled RR=3.45) than non-Indigenous women, but no increased risk of early-stage 
disease. These authors suggest that structural, social, or individual barriers to screening 
are possible factors that influence the poor health outcomes of Indigenous women and not 
baseline risk factors. 
Epidemiology of Cervical Cancer among Indigenous Women in Guyana 
 In Guyana, the Indigenous Amerindians live in the forests and experience the 
poorest health outcomes (Francis, Liverpool and Chan, 2009) and have the highest 
poverty levels (PAHO, 2013a). Similar reports of Indigenous people living in poverty in 
Latin American countries have also been documented (Moore et al., 2014). Compared to 
Indigenous people in other parts of the world, Latin American countries (Central America 
and Mexico, and South America) have a higher percentage of poverty (Moore et al., 








Table 6   















South Asia 95 44 
Southeast Asia 30 50 
Africa 22 77 
Arabia 15 7 
Central America and Mexico 12 75 
South America 11 82 
Rest of world 9 22 
Total 299 33 
 
Adapted from “Cancer in Indigenous People in Latin America and the Caribbean: A 
Review,” by S. P. Moore, D. Forman, M. Piñeros, S. M. Fernández, M. de Oliveira, and 
F. Bray, 2014, Cancer Medicine, 3(1), 76. 
 
The health status of Indigenous people in Guyana is affected by the apparent 
marked disparities that exist between the coastal communities and those communities in 
the hinterland, namely where the Indigenous Amerindians live (PAHO, 2012). For 
instance, Indigenous Amerindians experience social exclusion and hardship in accessing 
healthcare services because most of them reside in the underdeveloped areas in the 
interior where the delivery and provision of healthcare services and other essential 
services is hampered by the difficulty in getting to them (PAHO, 2013a). Factors 
impacting the delivery of healthcare services to Amerindian communities include limited 






 Cervical cancer and HPV-associated dysplasia are widespread among Indigenous 
women who live in remote areas (Goss et al., 2013; Kightlinger et al., 2010). Factors 
contributing to this increased prevalence are associated with limited access to Pap smear 
screening, HPV vaccination, and early treatment for cervical cancer (Kightlinger et al., 
2010). IAW in Guyana are not screened for cervical cancer because of the unavailability 
of large-scale systematic cervical cancer screening (Francis et al., 2009). Some factors 
impacting the provision of cervical cancer screening among this population are related to 
insufficient funding and equipment to conduct cervical cytology, lack of trained medical 
personnel, and geographic and logistic barriers in providing medical care in its remote 
areas (Francis et al., 2009;Kightlinger et al., 2010). 
Epidemiological data on the incidence of cervical cancer and HPV infection 
among Indigenous people in Guyana is limited. Indigenous people experience poorer 
health outcomes and higher mortality rates than non-Indigenous people (Demers et al., 
2012a; Goss et al., 2013; Moore et al., 2014). Research indicates that the high rates of 
morbidity and mortality among this population are as a result of lack of access to 
adequate screening and prevention services, low socioeconomic status, geographic and 
financial barriers (Best Plummer et al., 2009; Demers et al., 2012a; Goss et al., 2013; 
Kightlinger et al., 2010; Moore et al., 2014). As a result of these factors, the survival rate 
from cervical cancer tends to be poor since diagnosis and initial treatment of cervical 
cancer is delayed because manifestation of the disease is diagnosed at later stages (Goss 
et al., 2013, Moore et al., 2014). Early diagnosis and treatment of cervical cancer is 





will thus have a greater chance of being cured and living longer lives (Demers et al., 
2012a).  
 Low reporting of cervical cases for IAW is a major issue. This problem is 
compounded by the poor infrastructure that prevents access from getting to the remote 
villages to areas where health services are monitored and delivered (Kightlinger et al., 
2010; PAHO, 2012). Guyana has a cancer registry where data on the incidence rates of 
cervical cancer among IAW is limited or underreported. Figure 3 shows data on the 
number of cases by type and ethnicity as reported by the cancer registry. Cervical cancer 
cases for AGW (141) and IGW (137) are reported more than for IAW (31).  
  
Figure 3. Reported cases of cancer in Guyana, January 2004–December 2007. Adapted 
from “Guyana Country Cooperation Strategy 2010-2015,” by Pan American Health 




































 A review of the literature indicated that there is limited epidemiology data on the 
incidence of cervical cancer among indigenous populations. Indigenous women 
experience very high incidence and mortality rates of cervical cancer as compared to non-
Indigenous women. It is therefore important to understand the epidemiology and 
prevalence of cervical cancer and HPV among women who are at high risk. Providing 
opportunities for cervical cancer screening for Indigenous women in remote regions as 
well as for women in urban areas, and improving data collection could go a very long 
way in reducing health disparities in developing countries. The study design and methods 






Chapter 3: Research Method  
Introduction 
 The purpose of this quantitative study was to use secondary data from the Guyana 
Cancer Registry to examine the demographic variables and their relationship to cervical 
cancer among IAW, AGW, and IGW in Guyana. The dependent variable in the study was 
cervical cancer, and the independent variables were age, marital status, geographical 
regions, and stage at diagnosis this comparative cross-sectional study could help 
researchers better understand the association between the dependent variable and the 
independent variables. In this chapter I discussed the research design, study population 
and sample, sample size, data collection and data analysis methodology, and the ethical 
issues involved in the study.  
Research Questions 
My major aims in this study were to compare the cervical cancer cases among 
IAW, AGW, and IGW in Guyana and to use available risk factors from these data to 
answer the following research questions:  
RQ 1: Is there a difference in cervical cancer cases for Indigenous Amerindian 
women compared to Afro- and Indo-Guyanese women from 2000 through 2012? 
RQ 2: Is there an association between cervical cancer cases among Indigenous 






RQ 3: Is there a relationship in cervical cancer cases among Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women according to 
their ages, marital status, and year of diagnosis?  
RQ 4: Is there an association between the stage at diagnosis of cervical cancer and 
age, marital status, year of diagnosis, and geographical region among Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women? 
Research Design 
For this comparative cross-sectional study, I obtained preexisting data from the 
Guyana Cancer Registry from 2000 through 2012 and used them to assess demographic 
factors that were related to cervical cancer among IAW, AGW, and IGW. My reason for 
using this comparative study was to extrapolate findings from the reported cervical 
cancer cases and to apply these findings to these three ethnic groups of women. 
Study Population 
 For this study, I studied data from the three main ethnic groups, IAW, AGW, and 
IGW which included a total of 5800 cervical cancer cases from the study regions during 
the period 2000 to 2012. The study population included women from the three ethnic 
groups, age 13 and older who were diagnosed with invasive cervical cancer, cervical 
intraepithelial neoplasia I, II and III, high-grade squamous intraepithelial lesions, and 
low-grade squamous intraepithelial lesions with laboratory confirmation between 2000 
and 2012 from data reported to the Guyana Cancer Registry. I did not consider the total 





Guyana has a population of approximately 751,223 according to the 2002 census 
report (Bureau of Statistics, 2015b) and is made up of different ethnic groups including 
Indo-Guyanese, the largest group (43.5%), Afro-Guyanese (30.2%), mixed (16.7%), 
Amerindians (9.2%), and other groups (0.4%;PAHO, 2013a; Guyana Bureau of Statistics, 
2015b). In Guyana, there are ten regions classified as either remote and rural, coastal, or 
townships or the capital city, Georgetown (PAHO, 2013a; World Health Organization 
and Ministry of Health Guyana, 2008). According to the Guyana Bureau of Statistics 
(2015a), the urban townships are found in Regions 2, 4, 6 and 10. The coastland areas are 
in Regions 2, 3, 4, 5, 6 and 10, while the hinterland areas are primarily located in Regions 
1, 7, 8 and 9. Figure 4 below outlines the regional population distribution of Guyana, as 
of 2012. According to the Guyana Bureau of Statistics (2015a), the coastland regions 
which include the capital city have the higher percentage of the population (89.1%), 
while the population of the hinterland regions accounts for 10.9% of the total population. 
Additionally, Region 4 accounts for 41.9% of the population while Regions 6 and 3 have 








Figure 4. Regional Population Distribution for Guyana, 2012. Urban and Coastland 
Regions consist of Regions 2, 3, 4, 5, 6 and 10. The Hinterland Regions consist of Region 
1, 7, 8 and 9. Adapted from “Guyana Population and Housing Census 2012, Preliminary 
Report,” by the Guyana Bureau of Statistics, 2015a, VI.  
 
However, almost every ethnic group is found within each of these regions. Figure 
5 shows the regional population by nationality background and ethnicity. Afro-Guyanese 
are mainly concentrated in Region 4, while a higher percentage of Indo-Guyanese are 
primarily found in Regions 4, 6, and 3 respectively. Amerindians are found in Regions 1, 






Figure 5. Population by Nationality Background/Ethnicity by Region of Residence, 
Guyana: 2002. Adapted from “2002 Population and Housing Census, Guyana National 
Report, Chapter II: Population Composition,” by the Guyana Bureau of Statistics, 2015b, 
p. 30. 
  
 The percentage distribution for all ten regions based on the 2002 census is 
presented in Table 7. As seen in Table 7, Indigenous Amerindians account for more than 
three-quarters of the populations of Regions 8 and 9 (75.9% and 89.2% respectively) and 
two-thirds of the population of Region 1 (62.2%). Indo-Guyanese make up about one-half 
of the population in Regions 2 and 5, and more than two-thirds of the population of 
Region 3 (65.5%) and Region 6 (68.7%). Afro-Guyanese make up almost one-half of the 






Table 7   
Percentage Distribution of Population within a Region by Nationality, 





















































































































































































































































































Note: Only Regions 2, 3, 4, 5, 6 and 10 were included in this study Adapted from “2002 
Population and Housing Census, Guyana National Report, Chapter II: Population 
Composition,” by the Guyana Bureau of Statistics, 2015b, p. 31. 
 
 
For this study, I only reviewed data for IAW, AGW, and IGW from Regions 2, 3, 
4, 5, 6 and 10.The study regions with the three ethnic groups represented 75% of the 
national population. The Afro- and Indo-Guyanese representation in the study regions 
mirrored the overall national representation (30% and 43% respectively), while the 
Indigenous Amerindian represented only 3.74% of the study regions, a much smaller 
percentage than their overall national representation (9.14%).  
 As shown in Table 7, for the study population, Indo-Guyanese have the highest 





have the largest percentage distribution), followed by Afro-Guyanese and Indigenous 
Amerindians. Indigenous Amerindians represent more than three-quarters of the 
populations for Regions 8 and 9 (75.9% and 89.2% respectively) and two-thirds of the 
population for Region 1 (%). In contrast, Afro-Guyanese made up almost half of the 
populations of Regions 4 and 10 (41.67% and 54.98% respectively), while the Indo-
Guyanese made up approximately one-half of the populations for Regions 2 and 5 
(47.91% and 57.76%) and more than two-thirds of the populations for Regions 3 and 6 
(65.5% and 68.7% respectively; Guyana Bureau of Statistics, 2015a}.  
Rural and urban inequalities exist in relation to health care access, poverty, and 
health outcomes among the different ethnic groups in Guyana. My review of the literature 
however, revealed that there is very limited information related to the inequalities among 
the different ethnic groups in Guyana. Wilson et al. (2010) reported that although the 
Bureau of Statistics in Guyana publishes statistical information on mortality according to 
gender, disparity studies on the health of ethnic groups is either very limited or non-
existent. In the rural areas where the Indigenous Amerindians reside, access to health 
centers is hindered by the extensive travel required to reach them as compared to the 
access of other ethnic groups who live in the urban areas where better and easier 
transportation facilities are provided (Kightlinger et al., 2010). Poverty is linked to 
transportation disparity in health care access. Amerindians living in rural areas have the 
highest prevalence of poverty when compared to other ethnic groups in urban areas 
(PAHO, 2013a). Also, marked differences are observed in health outcomes between the 





among those of Indo-Guyanese, Chinese, and Portuguese ethnicity, while mortality rates 
due to neoplasms and AIDS were highest among Afro-Guyanese and Amerindian 
ethnicities (PAHO, 2013a).According to Wilson et al.’s (2010) study on the racial 
differences in physical and mental well-being in Guyana, Indo-Guyanese have 
significantly higher levels of impairment when compared to Afro-Guyanese. In another 
study that used data from the Guyana Cancer Registry populations to examine the 
prevalence of breast, cervical, and prostate cancers within different ethnicities in Guyana 
(Best Plummer et al., 2009), results showed that there was no significant difference 
between cervical and breast cancer incidence among Afro- and Indo-Guyanese women, 
but the cervical cancer cases among Indigenous Amerindian women were significantly 
higher (p<0.0001) than the cervical cancer cases of the Afro- and Indo-Guyanese women 
(Best Plummer et al., 2009).  
 The coastland area of Guyana is home to approximately 90% of the population, 
as shown in Table 8, the highest population distribution is found in Region 4 which 
includes the capital city (Guyana Bureau of Statistics, 2015a). The hinterland regions, on 
the other hand, consist of 10.9% of the population and these are not densely populated 
(Guyana Bureau of Statistics, 2015a). The regional population distribution for the periods 
2002 and 2012 is shown in Table 8 below. The population distribution was the same 
throughout years 2002 to 2012. In the ten-year period, there was very little change. Based 
on the average population statistics provided, in Regions 1, 2, 3, 4, and 5, the percentage 





8, 9, and 10, the percentage change for each region was15.5, 2.5, 1.3, 2.9, and 5.4 
respectively  
Table 8  
Regional Population Distribution (Male and Female), Guyana: 2002 and 2012 
 
Region Absolute Number Percent 
2002 2012 2002 2012 
Region 1 24,275 26,941 3.2 3.6 
Region 2 49,253 46,810 6.6 6.3 
Region 3 103,061 107,416 13.7 14.4 
Region 4 310,320 313,429 41.3 41.9 
Region 5 52,428 49,723 7 6.6 
Region 6 123,695 109,431 16.5 14.6 
Region 7 17,597 20,280 2.3 2.7 
Region 8 10,095 10,190 1.3 1.4 
Region 9 19,387 24,212 2.6 3.2 
Region 10 41,112 39,452 5.5 5.3 
Guyana 751,223 747,884 100 100 
Coastland 679,869 666,261 90.5 89.1 
Hinterland 71,354 81,623 9.5 10.9 
 
Note: The coastal regions are Regions 2, 3, 4, 5, 6 and 10, while the hinterland regions 
are Regions 1, 7, 8 and 9. Only Regions 2, 3, 4, 5, 6 and 10 were included in this study. 
Adapted from “Guyana Population and Housing Census 2012, Preliminary Report,” by 
the Guyana Bureau of Statistics, 2015a, p. 45. 
 
The gender distribution within the ten regions of Guyana varies (Guyana Bureau 
of Statistics, 2015a). In Table 9, the gender distribution and sex ratios for the periods 
2002 and 2012 are shown. Very little change has occurred in the pattern of the gender 
distribution in the 2012 census when compared to the 2002 census. According to the 





estimated ratio of 99 males for every 100 females (Guyana Bureau of Statistics, 2015a). 
However, in the 2002 census report, there were an almost equal number of males and 
females (100.2). As seen in Table 9, the largest sex differentials where the men 
outnumber the women (male to female ratio greater than 100) were observed in Regions 
1, 7, 8 and 9 in comparison to the coastland regions (Regions 2, 3, 4, 5, 6 and 10) where 
the sex ratio was low (96 males to every 100 females), especially in Region 4 (Guyana 
Bureau of Statistics, 2015a). This decrease might be attributed to male migration or other 
associated population factors such as population shift from the city to the city outskirt 
areas. According to the 2012 Guyana census report, male labor migration accounted for 
the higher sex ratio (more males than females) in the hinterland Regions (1, 7, 8 and 9) as 
compared to the coastland Regions (Guyana Bureau of Statistics, 2015a). According to 
the Guyana Bureau of Statistics, (2015a), this influx of male migration to the hinterland 
regions occurred as a result of the increased mining activities as well as opportunities for 
more economic gains. This high sex ratio within the hinterland regions however, has not 
been fully examined and further investigation is needed to assess this ongoing migration 
issue (Guyana Bureau of Statistics, 2015a).  
Comparatively, other studies have also discussed the difference in sex ratio as a 
result of migration. According to Dyson (2012), sex selective migration could impact the 
sex ratio of a population in terms of employment opportunities. The availability of 
lucrative employment such as mining or construction could influence the movement of 





male migration in terms of employment opportunities has been reported in countries such 
as China, South Africa and Saudi Arabia (Dyson, 2012).  
Table 9  
Gender Distribution and Sex Ratios, Guyana: 2002 and 2012 
 
 
Regions Population/Census Year Male-Female Ratios 
2002 2012 2002 2012 
Male Female Male Female 2002 2012 
Region 1 12,815 11,460 14,150 12,791 111.8 110.6 
Region 2 24,847 24,407 23,578 23,232 101.8 101.5 
Region 3 51,944 51,117 53,595 53,821 101.6 99.6 
Region 4 152,136 158,184 153,356 160,073 96.2 95.8 
Region 5 26,207 26,221 24,761 24,962 99.9 99.2 
Region 6 62,079 61,615 54,895 54,536 100.8 100.7 
Region 7 9,373 8,224 10,701 9,579 114 111.7 
Region 8 5,750 4,345 5,512 4,678 132.3 117.8 
Region 9 10,009 9,378 12,426 11,786 106.7 105.4 
Region 10 20,874 20,238 19,573 19,879 103.1 98.5 
Guyana 376,034 375,189 372,547 375,337 100.2 99.3 
Coastland 338,087 341,782 329,758 336,503 98.9 98 
Hinterland 37,947 33,407 42,789 38,834 113.6 110.2 
 
Note: The coastal regions are Regions 2, 3, 4, 5, 6 and 10, while the hinterland regions 
are Regions 1, 7, 8 and 9. Only Regions 2, 3, 4, 5, 6 and 10 were included in this study. 
Adapted from “Guyana Population and Housing Census 2012, Preliminary Report,” by 
the Guyana Bureau of Statistics, 2015a, p. 47. 
 
Table 10 shows the population distribution for the study regions which consisted 
of Regions 2, 3, 4, 5, 6, and 10 and based on the 2002 census information. There was no 
regional ethnic distribution in the 2012 census. All study-eligible cervical cancer cases 





regions were not used in this analysis. The regions with low data (Regions 1, 7, 8 and 9) 
were excluded due to having a very low case count. The number of cases for regions 1, 7, 
8 and 9 were 133, 136, 13 and 41 respectively compared to the case count in the study 
regions that exceeded more than 400 per region. The crude cervical cancer rate for these 
regions was calculated as follow: 
Crude case rate per 1000 = 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑎𝑛𝑐𝑒𝑟 𝑐𝑎𝑠𝑒𝑠 /𝑦𝑟
𝑊𝑜𝑚𝑒𝑛 𝑐𝑒𝑛𝑠𝑢𝑠 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛(2002) 
𝑋 1000 
Using the women 2002 population figures (Table 9), the crude cervical cancer rates were 
0.892 for Region 1; 1.272 for Region 7; 0.23 for Region 8; and 0.336 for Region 9. 
Comparatively, data from the other regions had a crude case rate greater than 1.11 cases 
per 1,000 persons with each region having a case count greater than 400 cases. In the 
study region, the crude case rate per thousand for IAW was 1.01 ({140/13} /10643} x 
1000) as compared to 2.16 for AGW ({3140/13} /111,757 x 1000) and 1.20 for 
IGW({2520/13} /162,033 x 1000).The computed numbers of women in the three ethnic 
groups for the study regions were 10,643 (IAW), 111,757(AGW) and 162,033(IGW) 












Table 10  

















Pop. 8014 2072 5244 1022 2016 2919 21287 
% 1.41 0.36 0.92 0.18 0.35 0.51 3.74 
AGW 
Pop. 6605 21880 129310 17065 26050 22604 223514 
% 1.16 3.85 22.73 3 4.58 3.97 39.29 
IGW 
Pop. 23598 67474 116494 30282 84953 1266 324067 
% 4.15 11.86 20.45 5.32 14.93 0.22 56.97 
Total  
  38217 91426 251048 48369 113019 26789 568868 
  6.72 16.07 44.13 8.5 19.87 4.71 100 
 
Note: The coastal regions are Regions 2, 3, 4, 5, 6 and 10, while the hinterland regions 
are Regions 1, 7, 8 and 9. Only Regions 2, 3, 4, 5, 6 and 10 were included in this study. 
Adapted from “Guyana Population and Housing Census 2012, Preliminary Report,” by 
the Guyana Bureau of Statistics, 2015a, p. 47. 
 
Sample Size Determination 
For this study, the sample size determination was conducted using Epi Info 7. The 
sample was chosen randomly from the population of 8,682 cervical cancer cases from the 
Guyana Cancer Registry for the period, 2000 to 2012. A 95% confidence level with a 
confidence limit of 5% and a design effect of 1 was determined for the sample size. 
Using this sample estimation information, 368 cervical cancer cases were randomly 
drawn from the database of 5800 valid cervical cancer cases. A case was considered valid 
if it fell within the age group of the study. Cervical cancer cases were selected according 
to ethnicity, age (ages were categorized into groups of 13-18 years; 19-24 years; 25-30 





67>years), marital status, geographical regions, year of diagnosis and stage at diagnosis 
for this study population. Figure 6 shows the sample size that was determined for the 
study population.  
 
Figure 6. Epi Info 7. Sample Size Calculations 
 
Study Variables 
 The independent variables in this study consisted of the following demographic 
variables: age (presented as ten groups: Group1 = 13-18 years; Group 2 =19-24 years; 
Group 3 =25-30 years; Group 4 = 31-36 years; Group 5 = 37-42 years; Group 6 = 43-48 
years; Group 7 = 49-54 years; Group 8 = 55-60 years; Group 9 = 61-66 years; and Group 
10 = 67>; marital status (categorized as single, married, divorced and unknown); and 
geographical regions. Guyana has ten regions which consist of the coastland and the 
hinterland regions (Guyana Bureau of Statistics, 2015a). Within the coastland regions 
(regions 2. 3, 4, 5, 6, and 10), the majority of Afro-Guyanese are primarily found in 





In contrast, the Indigenous Amerindians are located in the hinterland regions (regions 1, 
7, 8 and 9) with the majority living within Regions 1 and 9 (Guyana Bureau of Statistics, 
2015b). For this study, samples were drawn from the study regions (Regions 2, 3, 4, 5, 6 
and 10). The outcome variable is cervical cancer.  
Other variables that were measured in this study included ethnicity, year of 
diagnosis and the stages of cervical cancer. These stages consist of: a) Stage 0 referred to 
as carcinoma in situ where the cells are confined to the cervix; b) Stage I where the 
cancer is localized and is found in the cervix only; c) Stage II or the regional stage where 
the cancer has spread from the cervix but is confined to the pelvic region; d) Stage III 
where the cancer has spread to the lower third of the vagina but not unto the pelvic wall; 
and e) Stage IV or distant stage where the cancer has spread to other parts of the body 
(National Cancer Institute, 2015). According to the World Health Organization (WHO) 
(2008), when the cancer is in its early stage it is classified as Stages I and II while cancer 
in its advanced stage is grouped into Stage III and Stage IV.  
Guyana Cancer Registry Data Source 
 
This probability sample was identified through data obtained from the Guyana 
Cancer Registry (2015) from 2000 through 2012. For this study, I used data on the 
cervical cancer cases for the study population (IAW, AGW, and IGW). I also examined 
the demographic factors such as age, marital status, geographical regions as well as 
ethnicity, year of diagnosis and stage at diagnosis in relation to the cervical cancer cases 






Data Collection  
A Data Use Agreement form was obtained from Walden’s University Institutional 
Review Board (IRB) and signed between this researcher and the Guyana Cancer Registry 
in order to use the data from the Cancer Registry for this study.  
Data Analysis 
All data were analyzed by using predictive analytical statistics software, Statistical 
Package for the Social Sciences (SPSS) version 20. Data from 2000 through 2012 
inclusive for cervical cancer cases of women aged 13 and above from the Guyana Cancer 
Registry were analyzed by means of descriptive statistics involving frequencies, and 
confidence intervals which described the dependent variable (cervical cancer) and the 
independent variables (ethnicity, age, marital status, geographical regions, year of 
diagnosis and stage at diagnosis). Two-way contingency tables were used to examine the 
relationship between the dependent and independent variables. In addition, Chi-square 
statistics, Poisson regression, Exp (B) value, odds ratio, estimated incidence rate ratios, 
estimated relative risk, and 95% confidence intervals were also calculated. There were no 
appropriate denominators for the population at risk. Therefore, the odds ratio was used as 
a condition to approximate the risk. In a similar study population, San Sebastian & Hurtig 
(2004) used population estimates to develop denominators in order to estimate incidence 
and relative risk of cancers among indigenous people in the Amazon Basin of Ecuador.  
 The exponential beta (Exp B) value which gives the odd ratio of the dependent 
variable (Statistics Solution, 2016) was used to interpret the impact of each independent 





at the exponential of the coefficient on the independent variables and was interpreted in 
terms of the odds ratio. The Exp (B) for each category was estimated and divided by the 
Exp (B) of the reference category. These coefficients estimate the percentage difference 
in the absolute risk of cervical cancer cases for each region, relative to the reference 
category, Region 4. Also, the percentage difference in the absolute risk of cervical cancer 
cases for single/divorced, relative to the married category, and the younger age (by 
category) were calculated relative to the highest age category. Thus the Exp (B) 
coefficient was interpreted in terms of estimated incidence rate ratios which are 
exponentiated and are similar to the odds ratio (Statistics Solution, 2016). 
Pearson Chi-Square test based on an alpha-level of 0.05 was conducted to assess 
the differences in proportion of cervical cancer cases between the three ethnic groups of 
women. The proportion of cervical cancer cases for the three ethnic groups of women 
was also calculated by year to examine these differences.  
 Poisson Regression Model was calculated separately for each ethnic group of 
women to assess whether geographical region, age, marital status, and year of diagnosis 
were related to the number of cervical cancer cases. Estimated incidence rate ratios were 
calculated to assess the association between region, age, marital status, and year of 
diagnosis on the differences in the count of cervical cancer cases, relative to the reference 
categories. For this analysis, Region 4 (the largest region), the age category 10 (67> 
years), and the marital status (married) were used as the reference categories. 
Also, relative risk was calculated for geographical regions, age and marital status 





give the Exp (B) which is the expected number of cervical cancer cases. This same 
method was used to compare the relative risk between age and marital status among the 
three ethnic groups. 
To assess the association between the stage at diagnosis of cervical cancer and 
age, marital status, year of diagnosis, and geographical region, a logistic regression model 
was developed. The statistical significance was based on a 0.05 alpha level. The stage at 
diagnosis of cervical cancer was used as the dependent variable, and the age, marital 
status, year of diagnosis, and geographical region were used as the independent variables. 
The in-situ stage was used as the reference category because it is the first indication of 
the presence of cervical cancer. 
The rationale for choosing Logistic regression was to compare the cervical cancer 
rates between IAW to AGW and IGW as a combined group. Previous studies have shown 
that the incidence rate for Afro- and Indo-Guyanese is similar (Best Plummer, Persaud & 
Layne, 2009); therefore, it was plausible to combine the two groups in the analysis. 
According to O’Halloran & Econometrics (2008) and Anderson (2001), logistic 
regression assumptions assume: 1) the cases are independent; 2) the independent 
variables are not linear functions of each other; 3) the independent variables need not be 
interval levels; 4) normal distribution is not necessary or assumed for the dependent 
variable; and 5) the sample is ‘large’ – reliability of estimation declines when there are 
only a few cases. On the other hand, Poisson regression was used calculate odds ratio and 
relative risk in relation to the independent variables and the number of cervical cancer 





dependent variable consist of count data; 2) one or more independent variable can be 
measured on a continuous, ordinal or nominal/dichotomous scale; 3) there is 
independence of observations; 4) the distribution of counts follow a Poisson distribution; 
5) the mean and variance of the model are identical (Laerd Statistics, 2013). 
Data Analysis Plan 
Study Aim 1 
The primary aim of this study was to examine the difference in observed and 
expected cervical cancer cases for IAW compared to AGW and IGW from 2000 through 
2012. Frequency distribution tables were used to quantify the cervical cancer cases 
among the two groups as well as two-way contingency tables. In addition, chi-square test 
was also used to test for the differences of cervical cancer cases between IAW, AGW, 
and IGW.  
Study Aim 2 
The secondary aim of this study was to examine the association between cervical 
cancer cases among IAW, AGW, and IGW by geographical regions. Poisson regression 
with 95% confidence intervals was used to compare the cervical cancer cases to 
geographical regions.  
Study Aim 3 
The third aim of this study was to compare the relationship in cervical cancer 
cases among IAW, AGW, and IGW again after adjustment for demographic 





model was fitted to examine the associations between demographic characteristics and 
the estimated incidence rate ratio of cervical cancer cases.  
Study Aim 4 
 Aim 4 investigated the association between the stages at diagnosis of cervical 
cancer and age, marital status, year of diagnosis, and geographical region among IAW, 
AGW, and IGW by both crude and adjusted analyses. The actual ages were provided in 
the database obtained from the Guyana Cancer Registry. Marital status was categorized 
as single, married, and divorced. Crude estimates were examined using Multinomial 
Logistic Regression to obtain adjusted estimates. 
Tables were used for each of the statistical tests described in the data analysis 
plan. 
Strengths of the Data Analysis Plan 
 
This study used secondary data obtained from the Guyana Cancer Registry 
database. Using secondary data has its advantages in terms of being economical and less 
expensive to use; it can be replicated; and may improve measurement, sample size and 
representativeness (Frankfort-Nachmias & Nachmias, 2008). Another advantage of this 
study is that it is unique. No published studies were found which used data from the 
Guyana Cancer Registry to describe the relationship in cervical cancer cases among 
IAW, AGW, and IGW according to their age, marital status, geographical region, year of 





differences and relationships between variables by means of statistical tests are other 
strengths of this study.  
Summary 
 Chapter 3 presented the research design, study population, sample size, data 
collection and the data analysis and data analysis plan. This study used data that were 
obtained from the Guyana Cancer Registry database to examine the variables, ethnicity, 
age, marital status, geographical region, year of diagnosis and stage of diagnosis and their 
relationship to cervical cancer cases among IAW, AGW, and IGW in Guyana. Chapter 4 
provides a detailed description of the results of the findings of this study where each 






Chapter 4: Results 
Introduction 
The purpose of this study was to examine the relationship between cervical cancer 
and age, marital status, geographical regions, year of diagnosis, and stage at diagnosis of 
cervical cancer cases among IAW, AGW, and IGW in Guyana. In this study, I examined 
whether cervical cancer cases for IAW were different from AGW and IGW, whether 
geographical region was a significant predictor of cervical cancer cases among the three 
ethnic groups, and whether age, marital status, and year of diagnosis were related to the 
cervical cancer cases among these three ethnic groups. In addition, I examined the stage 
at diagnosis of cervical cancer in relation to age, marital status, year of diagnosis, and 
geographical regions among these three ethnic groups of women.  
Data Collection 
This research study was approved by Walden’s University Institutional Review 
Board, IRB Approval Number 12-18-14-0184632. A data use agreement was signed by 
me and a representative from the Guyana Cancer Registry. I secured data in a password-
protected database for confidentiality, and conducted the analysis using the SPSS 
Statistical Software, Version 20. 
Descriptive Statistics 
Data provided by the Guyana Cancer Registry consisted of 8,682 cervical cancer 
cases ranging in ages 0 to 100 years old during the years 2000 through 2012. The study 
population consisted of 5,800 cervical cancer cases from the dataset that I used for this 





age groups for this study (i.e. they were cases for individuals below age 13). In this 
chapter, I provide descriptive summaries of the cervical cancer cases within the study 
region by ethnicity, age, marital status, geographical regions, year of diagnosis, and stage 
at diagnosis. From the ten regions included in the dataset from the Guyana Cancer 
Registry, I only used data from regions 2, 3, 4, 5, 6, and 10. Regions 1, 7, 8, and 9 were 
not included because there was insufficient data to produce significant results.  
The trend in cervical cancer cases within the study region from 2000 through 
2012 for the three ethnic groups of women is presented in Figure 7.  
 
Figure 7. Trend in Cervical Cancer Cases Within the Study Region, 2000-2012 
 
The results in Figure 7 show that the majority of the cervical cancer cases for the 
IAW group occurred between the years 2003 to 2005 (25%), and that after 2005 there 
was a decreasing trend (14%). In contrast, the trend curve for the AGW group was a bit 
different. From the year 2000 through 2004, there was a growing trend of cervical cancer 
cases for this group. From 2005 through 2007, the percentages of the cervical cancer 





the years 2008 to 2009, there was a major decrease (15%). However, after 2009 to 
beyond 2010, the percentages of cervical cancer cases increased for the AGW group 
(approximately 19%). For the IGW group, there was a growing trend of cervical cancer 
cases from year 2000 onward. The peak occurred between the years 2006 to 2007 
(approximately 18%), and then there was a decrease in the percentage of cases. However, 
after the year 2009 to beyond 2010, there was, again, an increase in the percentages of 
cervical cancer cases for the IGW group (approximately 18%). 
Age Distribution 
 
Table 11 shows the age distribution of the cervical cancer cases within the study 
region for IAW, AGW, and IGW.  I categorized ages into ten groups in order to 
















Table 11  
Descriptive Summary of the Cervical Cancer Cases Within the Study Region by Ethnicity 




























IAW %  
 
Cases 
0.7 3.6 2.1 6.4 10.7 10.0 12.1 14.3 6.4 33.6 100 
1 5 3 9 15 14 17 20 9 47 140 
 
AGW %  
 
Cases 
0.6 1.0 2.1 3.2 6.1 8.7 10.8 11.2 11.8 44.5 100 





1.2 1.5 2.2 4.8 8.7 12.5 14.8 13.8 12.7 27.8 100 
30 38 55 121 220 315 373 348 320 700 2520 
  
Total 
Cases 51 73 124 232 425 603 728 719 700 2145 5800 
 
The results showed that for all three ethnic groups, the highest percentages of 
cervical cancer cases were found in the 67 years and older age group. This indicates that 
nearly half of the women over 67 years were diagnosed with cervical cancer. I found that 
the second largest percentage of cervical cancer cases occurred in the 55 to 60 years old 
age group for IAW and IGW (14.3% and 13.8% respectively), followed by the 49-54 
years age group where IAW (12.1%) and IGW (14.8%) accounted for the larger number 
of cases. The results showed that cervical cancer cases were more common in IAW age 









Table 12 presents the descriptive statistics of the cervical cancer cases within the study 
region by marital status for the study period, 2000 through 2012. Marital status was 
categorized as single, married, divorced, and unknown. 
Table 12  
Descriptive Summary of Cervical Cancer Cases Within the Study Region by Marital 
Status, 2000-2012 
 
  MARITAL STATUS  
Total 




30 26.4 1.4 42.1 100 
42 37 2 59 140 
AGW %  
Cases 
25.4 22.6 1.8 50.3 100 
797 709 55 1579 3140 
IGW % 
Cases 
18.1 25.5 0.6 55.8 100 
456 643 16 1405 2520 
Total 1295 1389 73 3043 5800 
 
The results showed that the “unknown” status of cervical cancer cases for all three groups 
was dominant. The “unknown” group accounted for 52.5% of the 5800 cervical cancer 
cases (3,043). The second largest group of cervical cancer cases (1, 389) was in the 
“married” category (24%), followed by the “single” category with 1,295 cervical cancer 
cases (22.3%). The results showed there were only a few cervical cancer cases for the 
“divorced” category (73 cases = 1.3%). In addition, the results showed that the “single” 
and “married” statuses of cervical cancer cases of IAW were 30% and 26.4% 
respectively. For AGW there were 25.4% and 23% cases respectively, while for the IGW, 






 Table 13 shows the results of the distribution of cervical cancer cases by ethnicity 
and region for the study period, 2000 through 2012.  
I derived the number of ethnic women for each study region from the equation: 
Number of women = 
100
100 +(𝑀𝑎𝑙𝑒−𝐹𝑒𝑚𝑎𝑙𝑒 𝑆𝑒𝑥 𝑅𝑎𝑡𝑖𝑜) (𝑇𝑎𝑏𝑙𝑒 9)
 ×𝑆𝑡𝑢𝑑𝑦 𝑅𝑒𝑔𝑖𝑜𝑛 𝑃𝑜𝑝. 
The total number of IAW women in the study region was 10714, while the total number 
AGW and IGW women were 112, 672 and 162,617 respectively.  
In Table 13, the population of IAW, AGW, and IGW with regions 1, 7, 8 and 9 
excluded were 568, 868 for 2002. The population percentage of IAW, AGW, and IGW 
for the study Regions, 2, 3, 4, 5, 6 and 10 were 3.74%, 39.29% and 56.97% respectively 
(See Table 10).The crude case rate per 1000(
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑎𝑛𝑐𝑒𝑟 𝑐𝑎𝑠𝑒𝑠 /𝑦𝑟
𝑊𝑜𝑚𝑒𝑛 𝑐𝑒𝑛𝑠𝑢𝑠 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛(2002) 
𝑋 1000) for IAW in 
the study region was 1 ([140/13/(10714)] x 1000) as compared to 2.14 for AGW 













Table 13  
Descriptive Summary of Cervical Cancer Cases Within the Study Region by Ethnicity and 






Region 2 Region 3 Region 4 Region 5 Region 6 Region 10 
Cases % Cases % Cases % Cases % Cases % Cases % 
ETHNICITY IAW  28 20.0 6 4.3 66 47.1 6 4.3 18 12.9 16 11.4 140 100 
AGW  125 4.0 251 8.0 1949 62.1 208 6.6 306 9.7 301 9.6 3140 100 
IGW  288 11.4 414 16.4 1051 41.7 189 7.5 562 22.3 16 .6 2520 100 
Total 441 7.6 671 11.6 3066 52.9 403 6.9 886 15.3 333 5.7 5800 100 
 
The results in Table 13 show that the majority of the cervical cancer cases were 
from Region 4 which comprised 44.13 % of the study population (see Table 10) and had 
52.9% of the cervical cancer cases. In the study region, 0.92 % of the IAW resided in 
Region 4 (see Table 10) where 47.1% of all IAW cervical cancer cases were observed. 
The AGW and IGW populations for the Region 4 study population were 22.73% and 
20.45% respectively (Table 10), and accounted for 62.1% and 41.7% respectively of the 
overall cervical cancer cases. For the IAW, the second largest share of cervical cancer 
cases were from Region 2 (20.0%), while for AGW and IGW, the second largest share of 









Table 14 presents the results of the distribution of cervical cancer cases in the 
study region by ethnicity and stage at diagnosis for the study period, 2000 through 2012. 
The four stages of cervical cancer considered for this analysis were In situ, Localized, 
Regional, and Distant. Among these four stages, more than 70% of the cervical cancer 
cases were observed to be at the “Localized” stage, followed by the “Regional” stage 
which had the second largest share of cervical cancer cases. When compared to the 
“Localized” and “Regional” stages, the “Distant” stage had fewer cervical cancer cases 
but more than the In-situ stage where the lowest number of cervical cancer cases were 
diagnosed. 
Table 14  
Descriptive Summary of Cervical Cancer Cases Within the Study Region by Ethnicity and 







In situ Localized Regional Distant 
Cases % Cases % Cases % Cases % 
ETHNICITY. IAW  1 1.22 58 70.73 12 14.63 11 13.41 82 100 
AGW  9 0.45 1451 72.84 304 15.26 228 11.45 1992 100 
IGW  8 0.44 1311 72.55 301 16.66 187 10.35 1807 100 
Total 18 0.46 2820 72.66 617 15.90 426 10.98 3881 100 
 





The results of the analysis in Table 14 of the cervical cancer cases by ethnicity 
and stage of cancer followed an overall pattern. For IAW, AGW and IGW, the 
“Localized” stage had the largest share of cases (70.7%, 72.7% and 73.2% respectively), 
followed by the “Regional” stage which had the second largest share of cases (14.6%, 
15.4%, 16.6% respectively).  
Research Questions and Hypotheses 
Research Question 1 
 Is there a difference in cervical cancer cases for Indigenous Amerindian women 
compared to Afro- and Indo-Guyanese women from 2000 through 2012?  
The results showed that there is a significant difference in cervical cancer cases for 
IAW when compared to AGW and IGW from 2000 through 2012. The results of the 
analysis were statistically significant, Pearson X2(5, N = 5800) = 19.739, p <0.05). 
Therefore, the null hypothesis was rejected. 
 Table 15 presents the expected and observed counts of cervical cancer cases for 










Table 15  
Pearson Chi-Square to Predict Differences in Percentages Between Cervical Cancer 
Cases Within the Study Region for Indigenous Amerindian Women When Compared to 
Afro-and Indo-Guyanese Women, 2000-2012  
Note: 1% of IAW in the study region = 3.74%; Observed number of cervical cancer cases = 140; 2% f AGW 
in the study region = 39.29%; Observed number of cervical cancer cases = 3140; 3% of IGW in the study 
region = 56.97%; Observed number of cervical cancer cases = 2520. 
Chi-Square Tests 
 
Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 19.739a 10 .032 
Likelihood Ratio 20.607 10 .024 
Linear-by-Linear Association .004 1 .947 
N of Valid Cases 5800 
  
Note: a0 cells (.0%) have expected count less than 5. The minimum expected count is 19.00. 





































































































































































The results in Table 15 showed that the percentage of cervical cancer cases for 
IAW for the years 2004-2005 was 25.7% as compared to 18.5% and 17.3% for AGW and 
IGW respectively. For the IAW, there was a notably decrease in the percentage of 
cervical cancer cases observed for the years 2008 and beyond. For AGW and IGW, there 
was an increase in the percentage of cervical cancers cases for 2002 through 2009. In 
addition, the results of the analysis showed that for IAW and IGW, the expected count of 
cervical cancer cases was greater than the observed count (217 vs. 140 for IAW) and 
(3304 vs. 2520 for IGW) while the expected count was less than the observed count for 
AGW (2279 vs. 3140).  
Research Question 2 
Is there an association between cervical cancer cases among Indigenous 
Amerindian women, Afro-Guyanese women, and Indo-Guyanese women and their 
geographical regions? 
The results showed that there is a significant association between cervical cancer 
cases for IAW, AGW, and IGW and their geographical regions (p <0.05). This 
information therefore provides evidence to reject the null hypothesis. 
Table 16 below presents the results from the Poisson Regression analysis of the 
cervical cancer cases for IAW and their geographical regions. The estimated incidence 
rate ratios of cervical cancer cases in Regions 2 and 5 were significant (p<0.05). IAW in 
Region 2 have a 20% greater chance of getting cervical cancer than IAW in Region 4. 







Table 16  
Poisson Regression of Cervical Cancer Cases Within the Study Region for Indigenous 









95% Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0 69.955 60.854 80.416 
[REGION=2] 0.136 1.2 0.944 1.526 
[REGION=3] 0.536 0.848 0.504 1.428 
[REGION=5] 0.137 0.636 0.35 1.155 
[REGION=6] 0.674 1.065 0.794 1.429 
[REGION=10] 0.307 0.838 0.597 1.176 
[REGION=4] 
(REFERENCE) 
. 1 . . 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category. Model: (Intercept), Region. Absolute Risk 
(IAW/Region 4) = 1.21% (69.955/5800 x 100%).  
 
Table 17 presents the results of the Poisson Regression analysis of the cervical 
cancer cases within the study regions for AGW and their geographical regions. The 













Table 17  
Poisson Regression of Cervical Cancer Cases From the Study Region for Afro-Guyanese 










95%Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0 1741.141 1701.036 1782.192 
[REGION=2] 0.112 0.879 0.795 0.972 
[REGION=3] 0.886 1.005 0.938 1.077 
[REGION=5] 0.01 0.091 0.833 0.975 
[REGION=6] 0.558 0.981 0.92 1.046 
[REGION=10] 0.123 0.95 0.89 1.014 
[REGION=4] 
(REFERENCE) 
. 1 . . 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category.  Model: (Intercept), Region. Absolute Risk 
(AGW/Region 4) = 30.01% (1741.141/5800 x 100%).  
 
Table 18 presents the results of the Poisson Regression analysis of the cervical 
cancer cases within the study regions for IGW and their geographical regions. The results 
showed that the approximated incidence rate ratio of cervical cancer cases for IGW in 
Regions 5 was significant (p < 0.05). IGW in Region 5 have a 2.5% less chance of 













Table 18  
Poisson Regression of Cervical Cancer Cases Within the Study Region for Indo-









95%Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0 4549.782 4505.954 4594.036 
[REGION=2] 0.965 1 0.98 1.022 
[REGION=3] 0.71 1.003 0.985 1.022 
[REGION=5] 0.047 0.975 0.951 1 
[REGION=6] 0.79 0.998 0.982 1.014 
[REGION=10] 0.267 0.955 0.881 1.036 
[REGION=4] 
(REFERENCE) 
. 1 . . 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category. Model: (Intercept), Region. Absolute Risk 
(IGW/Region 4) = 78.44% (4549.782/5800 x 100%).  
 
The results in Table 19 showed the expected risk of cervical cancer cases by 
geographical region and the ethnic groups. The expected risk of cervical cancer cases for 
the AGW and IGW was less than that in the reference Region 4 for all regions (2, 5, 6, 
and 10) except Region 3 where it was greater than that of the reference region (1.05 and 
1.03 respectively). The results also showed that Regions 2 and 4 were predictors of 
cervical cancer cases for IAW while Region 4 was a predictor of cervical cancer cases for 







Table 19  
Expected Risk of Cervical Cancer Cases by Study Region and Ethnic Groups  
 
Regions  













95% CI  
Lower Upper Lower Upper Lower Upper 
2 1.2 0.944 1.526 0.88 0.795 0.972 1 0.98 1.022 
3 0.85 0.504 1.428 1.05 0.938 1.077 1.03 0.985 1.022 
5 0.64 0.35 1.155 0.9 0.833 0.975 0.98 0.951 1 
6 1.07 0.794 1.429 0.9 0.92 1.046 0.98 0.982 1.014 
10 0.84 0.597 1.176 0.95 0.89 1.014 0.96 0.881 1.036 
Note. *Reference category = Region 4 
 
Research Question 3 
Is there a relationship in cervical cancer cases among Indigenous Amerindian 
women, Afro-Guyanese women, and Indo-Guyanese women according to their ages, 
marital status, and year of diagnosis?  
The results from the Poisson Regression analysis showed there was a statistically 
significant relationship in cervical cancer cases among IAW, AGW, and IGW according 
to their ages (p < 0.00; 95% CI). Therefore, the null hypothesis was rejected. 
 Table 20 presents the results of the Poisson Regression analysis within the study 
region for the cervical cancer cases among AGW according to age, marital status, and 
year of diagnosis. The results in Table 20 showed that age (p <0.001) and being single (p 
< .05) were significant predictors for cervical cancer cases but the year of diagnosis was 
not significant (p > 0.05) relative to the cervical cancer cases among AGW. The results 





diagnosed with cervical cancer compared to AGW, 55 years and older (OR ≤ 2.483). 
AGW who are married have a greater chance of being diagnosed earlier for cervical 
cancer than single AGW (OR = .962; p < 0.05). 
Table 20  
Poisson Regression to Predict the Relationship Between Cervical Cancer Cases and Age, 
Marital Status, and Year of Diagnosis Among Afro-Guyanese Women Within the Study 
Region, 2000-2012  
 
Independent Variable p-value *Exp(B)) 
95% Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0.183 26.106 0.214 3177.899 
Age Group1 = 13-19 years  0 3.949 3.665 4.255 
Age Group2 = 19-24 years 0 3.892 3.66 4.14 
Age Group 3 = 25-30 years 0 3.822 3.659 3.993 
Age Group 4 = 31-36 years 0 3.71 3.575 3.85 
Age Group 5 = 37-42 years 0 3.537 3.432 3.645 
Age Group 6 = 43-48 years 0 3.257 3.169 3.347 
Age Group 7 = 49-54 years 0 2.887 2.811 2.965 
Age Group 8 = 55-60 years 0 2.483 2.415 2.552 
Age Group 9 = 61-66 years 0 2.049 1.991 2.109 
Age Group 10 = 67> years . 1 . . 
[marital status=Single] 0.002 0.962 0.94 0.986 
[marital status=Divorced] 0.369 0.971 0.912 1.035 
[marital status=Unknown] 0.314 0.989 0.969 1.01 
[marital status=Married] . 1 . . 
Year 0.155 1.002 0.999 1.004 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category (Married). Model: (Intercept), Region. Absolute Risk 
(AGW Age Group 10 & Married) = 0.45% (26.106/5800 x 100%). 
 
The results in Table 21 showed that age (p < 0.001), being single (p < .05), and 





IGW. The results also showed that IGW 30 years or younger (OR ≥ 1.571) have a greater 
chance of being diagnosed with cervical cancer as compared to IGW who are 55 years 
and older (OR ≤ 1.232). 
Table 21  
Poisson Regression to Predict the Relationship Between Cervical Cancer Cases and Age, 










95% Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0 1421.236 684.07 2952.783 
(Intercept) 0 1.597 1.58 1.613 
Age Group1 = 13-19 years  0 1.584 1.569 1.598 
Age Group2 = 19-24 years 0 1.571 1.559 1.584 
Age Group 3 = 25-30 years 0 1.547 1.539 1.556 
Age Group 4 = 31-36 years 0 1.5 1.493 1.507 
Age Group 5 = 37-42 years 0 1.426 1.42 1.432 
Age Group 6 = 43-48 years 0 1.332 1.326 1.337 
Age Group 7 = 49-54 years 0 1.232 1.227 1.237 
Age Group 8 = 55-60 years 0 1.14 1.135 1.145 
Age Group 9 = 61-66 years 0.049 0.996 0.992 1 
Age Group 10 = 67> years . 1 . . 
[marital status=Single] 0.594 0.996 0.981 1.011 
[marital status=Divorced] 0.803 1 0.997 1.003 
[marital status=Unknown] . 1 . . 
[marital status=Married] . 1 . . 
Year 0.012 1 1 1.001 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category (Married). Model: (Intercept), Region. Absolute Risk 
(IGW Age Group 10 & Married) = 24.5% (1421.236/5800 x 100%). 
 
The results in Table 22 showed that age was a statistically significant predictor of 





younger (OR ≥ 5.479) have a greater chance of being diagnosed with cervical cancer as 
compared to IAW who are 55 years and older (OR ≤ 2.797).  
Table 22  
Poisson Regression to Predict the Relationship Between Cervical Cancer Cases and Age, 
Marital Status, and Year of Diagnosis Among Indigenous Amerindian Women Within the 
Study Region, 2000-2012 
  
Independent Variable p-value *Exp(B) 
95% Confidence Interval for Exp(B) 
Lower Upper 
(Intercept) 0.899 0.158 7.41E-14 3.39E+11 
Age Group1 = 13-19 years  0 5.713 4.191 7.788 
Age Group2 = 19-24 years 0 5.681 4.81 6.711 
Age Group 3 = 25-30 years 0 5.479 4.484 6.695 
Age Group 4 = 31-36 years 0 5.309 4.601 6.127 
Age Group 5 = 37-42 years 0 4.798 4.213 5.463 
Age Group 6 = 43-48 years 0 4.163 3.631 4.772 
Age Group 7 = 49-54 years 0 3.566 3.115 4.081 
Age Group 8 = 55-60 years 0 2.797 2.429 3.22 
Age Group 9 = 61-66 years 0 2.183 1.812 2.631 
Age Group 10 = 67> years . 1 . . 
[marital status=Single] 0.359 1.048 0.948 1.159 
[marital status=Divorced] 0.563 0.906 0.648 1.266 
[marital status=Unknown] 0.279 1.052 0.96 1.153 
[marital status=Married] . 1 . . 
Year 0.731 1.002 0.988 1.017 
Note. *IRR estimated based on the Poisson regression coefficient Exp (B). Each Exp (B) of each category 
was divided by the Exp (B) of the reference category (Married). Model: (Intercept), Region. Absolute Risk 
(IAW Age Group 10 & Married) = 0.0027% (0.158/5800 x 100%).  
 
Table 23 presents the relative risk of cervical cancer cases by age and marital 





risk of getting cervical cancer than their married counterparts as compared to AGW (0.96) 





Table 23  
Relative Risk of Cervical Cancer Cases by Age and Marital Status Among Indigenous 
Amerindian, Afro- and Indo-Guyanese Women Within the Study Region, 2000-2012 




Relative Risk Single 
vs. Married (%) 
95% Confidence Interval For 
Exp(B) 
     Lower Upper 
IAW 13-18 0.949 0.906 1.05 0.996 1.101 
 19-24 0.945 0.900 1.05 0.996 1.101 
 25-30 0.910 0.868 1.05 0.996 1.101 
 31-36 0.882 0.841 1.05 0.996 1.101 
 37-42 0.797 0.760 1.05 0.996 1.101 
 43-48 0.691 0.656 1.05 0.996 1.101 
 49-54 0.592 0.565 1.05 0.996 1.101 
 55-60 0.464 0.443 1.05 0.996 1.101 
 61-66 0.362 0.346 1.05 0.996 1.101 
AGW 13-18 99.19 103.03 0.96 0.915 1.011 
 19-24 97.81 101.59 0.96 0.915 1.011 
 25-30 96.06 99.78 0.96 0.915 1.011 
 31-36 93.22 96.83 0.96 0.915 1.011 
 37-42 88.85 92.29 0.96 0.915 1.011 
 43-48 81.85 85.03 0.96 0.915 1.011 
 49-54 72.53 75.34 0.96 0.915 1.011 
 55-60 62.36 64.78 0.96 0.915 1.011 
 61-66 51.52 53.52 0.96 0.915 1.011 
IGW 13-18 2259.73 2268.77 1.00 0.946 1.046 
 19-24 2241.72 2250.71 1.00 0.946 1.046 
 25-30 2223.86 2232.77 1.00 0.946 1.046 
 31-36 2188.56 2197.33 1.00 0.946 1.046 
 37-42 2121.76 2130.30 1.00 0.946 1.046 
 43-48 2018.28 2026.37 1.00 0.946 1.046 
 49-54 1883.71 1891.26 1.00 0.946 1.046 
 55-60 1744.11 1751.10 1.00 0.946 1.046 
 61-66 1613.24 1619.71 1.00 0.946 1.046 
 
     





Research Question 4 
Is there an association between the stage at diagnosis of cervical cancer and age, 
marital status, year of diagnosis, and geographical region among Indigenous Amerindian 
women, Afro-Guyanese women, and Indo-Guyanese women? 
The results showed that there is a statistically significant association between the 
stage at diagnosis of cervical cancer and age (p<.05); marital status (p<.05); year of 
diagnosis (p<.05); and geographical region (p<.05) among IAW, AGW, and IGW. The 
year of diagnosis for the localized, regional, and distant stages is less than expected, 
whilst the marital status for the distant stage is less than expected. This information 
provides evidence to reject the null hypothesis.  












Table 24  
Multinomial Logistic Regression of the Association Between the Stage at Diagnosis of 





95% Confidence Interval for 
Exp(B) 
[odds ratio] Lower Bound Upper Bound 
Localized 
Intercept 0.001       
Year 0.001 0.72 0.592 0.876 
Age 0.004 1.338 1.1 1.628 
Mstatus 0.181 0.717 0.441 1.167 
ETHNICITY 0.167 1.844 0.774 4.395 
REGION 0.018 1.753 1.102 2.789 
Regional 
Intercept 0.049       
Year 0.049 0.82 0.674 0.999 
Age 0.006 1.319 1.082 1.608 
Mstatus 0.069 0.635 0.389 1.036 
ETHNICITY 0.123 1.995 0.829 4.802 
REGION 0.013 1.803 1.131 2.873 
Distant 
Intercept 0.011       
Year 0.011 0.773 0.634 0.942 
Age 0.003 1.356 1.11 1.657 
Mstatus 0.003 0.47 0.288 0.769 
ETHNICITY 0.222 1.737 0.717 4.211 
REGION 0.018 1.754 1.099 2.8 
Note. Reference category = In situ 
 The results in Table 24 showed that compared to the reference in situ stage, early 
diagnosis is likely to decrease the chances of getting to the localized, regional, and distant 
stages. This indicates that for one unit increase in the year of diagnosis, there would be a 
28% reduction of going to the localized stage, an 18% reduction of going to the regional 





 With regards to the age of women, the results of the multinomial logistic 
regression showed that when compared with the in situ stage (which was the reference 
category), as age increased, there was less likelihood of the cases being localized, and 
cases for the older age group were more likely to be in the in situ stage. There was a 
1.228 times more probability of getting to the localized stage; 1.319 times more 
probability of getting to the regional stage; and 1.356 times more probability of getting to 
the distant stage. Cervical cancer cases that were diagnosed later were more likely to be 
in the in situ stage. 
 With regards to the marital status in comparison to the distant stage, the results of 
the multinomial regression analysis showed that as a single woman’s marital status was 
changed to married or divorced status, she had a 53% less chance of moving to the distant 
stage when compared to the in-situ stage.  
In addition, the results of the multinomial regression analysis showed that with 
regards to region when compared to the in-situ stage, as the population density increases, 
there is a likelihood for the women to be diagnosed at the localized, regional, and distant 
stages (OR = 1.753; OR = 1.803; and OR = 1.754 respectively), particularly for each 
cervical cancer case in the in-situ stage where there would be about 1.75 times more 
cases for those women who are in the localized, regional, and distant stages.  
Summary 
 The results from this study showed that there was a statistically significant 
association between cervical cancer cases and the age, marital status, geographical 





proportionally higher cervical cancer cases than both AGW and IGW. In addition, the 
results showed that geographical region was a strong predictor of cervical cancer cases 
when comparing the different ethnic groups of women. Remote and dense urban areas 
were most likely to contribute to the higher cervical cancer rates. There was a statistically 
significant relationship between age and marital status of getting cervical cancer among 
IAW, AGW and IGW. The number of cervical cancer cases for married women exceeded 
that of single women (24% to 22.3%) but yet the single women were more likely to be 
diagnosed with cervical cancer. Women in the 13-18 age groups had a high risk of being 
diagnosed with cervical cancer and this age group appears to be a driver for cervical 
cancer in single women. Divorce was not a predictor of cervical cancer cases among the 
three ethnic groups of women. The year of diagnosis was only an important predictor of 
cervical cancer cases among IGW. Cervical cancer cases among IGW tend to increase 
over time. This may be as a result of migration to high risk or remote areas. In addition, 
the results showed that among all three ethnic groups, the women are more likely to 
develop later stage cervical cancer as they progress in age.  
 The findings, social implications, and recommendation for future study are 










Chapter 5: Discussion, Recommendations, and Conclusion 
Discussion  
 The findings from this study showed that IAW, AGW, and IGW in Guyana were 
affected by cervical cancer. In this study, I examined the relationship between cervical 
cancer cases and age, marital status, geographical regions, year of diagnosis, and stage at 
diagnosis of cervical cancer cases among IAW, AGW, and IGW in Guyana. I used 
Pearson’s chi-square, multinomial logistic regression, and Poisson regression to examine: 
(a) whether there were differences in the cervical cancer cases for IAW compared to 
AGW and IGW from 2000 through 2012; (b) whether cervical cancer cases among IAW, 
AGW, and IGW were associated with geographical regions; (c) whether there was a 
relationship between cervical cancer cases among IAW, AGW, and IGW and their ages, 
marital status, and year of diagnosis; and (d) whether the stage at diagnosis of cervical 
cancer was associated with age, marital status, year of diagnosis, and geographical region 
among IAW, AGW, and IGW. In this chapter, I present interpretations of the findings, 
discuss the strengths and limitations of this research study, and conclude with a 
discussion of the social change implications and future research recommendations for 
these three ethnic groups of women in Guyana. 
Interpretation of the Findings 
In this study, I addressed four research questions in an attempt to determine the 
relationship between cervical cancer cases and age, marital status, geographical region, 
year of diagnosis, and stage at diagnosis of cervical cancer among three ethnic groups of 





Findings for Research Question 1 indicated that there were significant differences 
in cervical cancer cases by ethnicity. IAW had a lower case rate (cases per thousand 
persons) of cervical cancer as compared to AGW and IGW women. The crude cervical 
cancer case rate per thousand was 1.01 for IAW, 2.16 for AGW, and 1.20 for IGW. These 
rates suggest that the IAW are less likely to be diagnosed with cervical cancer when 
compared with the women in the other ethnic groups in the study regions 2, 3, 4, 5, 6, and 
10. Regions 1, 7, 8, and 9 (which I excluded from the study) have about 60% of the 
Indigenous population, but no significant data was available for these regions. The data 
from the Guyana Cancer Registry covered regions where more than 98.5% of AGW and 
IGW reside. AGW were more likely to be affected by cervical cancer than the IGW, 
while IAW may not have been proportionally represented in the data collection. Most 
Amerindians tend to live in areas remote from population centers where access to 
healthcare centers is limited, thereby also impacting data acquisition for this population. 
Previous researchers have also shown that Indigenous women have higher rates of 
cervical cancer when compared to non-Indigenous women (Moore et al., 2013; San 
Sebastian, & Hurtig, 2004). Risk factors related to this high incidence of cervical cancer 
among Indigenous Amerindian include numerous childbirths, sexual intercourse at an 
early age, low socioeconomic status, and limited access to health care services (Best 
Plummer et al., 2009).    
 For Research Question 2, the expected risk of cervical cancer cases for 
Indigenous Amerindian women in Regions 2 and 6 was greater by 20% and 6.5% 





cervical cancer was more likely to occur in urban areas than in the rural areas. 
Comparatively, the expected risk of cervical cancer cases for IAW was less in Regions 3, 
5, and 10. This result may be indicative of lack of access to healthcare facilities for IAW 
in Region 2 and 6. The geography of Amerindian villages in these study regions, as well 
in those regions (1, 7, 8, and 9) that were not included in this study, often isolates them 
from population centers where healthcare facilities are more likely to be present. In 
addition, although Indigenous Amerindians comprise of 9.14% of the total population of 
Guyana, a total of 59.1% of this population did not reside in the study regions as per the 
2002 population census. Comparatively, the AGW and IGW were overrepresented in the 
study regions by about 30% and 31% respectively. This overrepresentation suggests that 
there was underreporting of cervical cancer cases for IAW, and that the majority of the 
Afro- and Indo-Guyanese populations most likely resided in areas that were closest to 
healthcare facilities. Region 4, which consists of the capital city and other large urban 
centers, had the majority of the cervical cancer cases for each ethnic group, which is 
reflective of the presence of easily accessible health care facilities. 
 Additional findings from this study showed that AGW in Region 4 were at a 
higher risk of getting cervical cancer as compared to AGW in the other study regions 
(Regions 2, 3, 5, 6, and 10). There was no regional significance of cervical cancer cases 
for IGW. Thus, the findings of this study which showed that geographical region is a 
predictor of cervical cancer cases are consistent with previous studies from some 
developing countries (Best Plummer et al., 2009; Moore et al., 2014; Shannon et al., 





access to goods and services, employment, and income that exist between the 
coastal/urban regions and the hinterland regions of Guyana. The coastal areas are located 
in Regions 2, 3, 4, 5, 6, and 10, while the urban areas are found in Regions 2, 4, 6 and 10, 
and the hinterland areas are in Regions 1, 7, 8 and 9 (Guyana Bureau of Statistics, 
2015a). Indigenous Amerindians primarily reside in Regions 1, 7, 8, and 9 (regions not 
included in this study), but few are located in Regions 2 and 4. Afro-Guyanese reside 
mainly in Regions 3, 4, 6, and 10, with few in Region 5. Indo-Guyanese are primarily 
found in Regions 3, 4, and 6, but not many are found in Regions 2 and 5 (CARICOM 
Secretariat, 2009).  
Marked disparities relating to poverty, access to goods and services, employment 
opportunities, and income levels disproportionately affect the coastal/urban and 
hinterland communities (PAHO, 2012). The differences I observed in the incidence rate 
ratios of cervical cancer cases among the three ethnic groups of women in Regions 2, 3, 
5, 6, and 10 could be explained by contextual, sociodemographic, and environmental 
factors. Indigenous Amerindians have the highest poverty levels (PAHO, 2012) and also 
experience the poorest health outcomes (Francis et al., 2009). Additionally, IAW are 
disproportionately affected by limited access to healthcare services, limited resources, 
and geographic barriers including poor infrastructure, transportation difficulties, and 
difficult terrains (PAHO, 2012). Furthermore, while better qualified health workers are 
found within the coastal/urban regions, the hinterland regions experience a shortage of 





provision of adequate cervical cancer screening among IAW (Francis et al., 2009; 
Kightlinger et al., 2010; PAHO, 2012).  
For Research Question 3, additional findings showed that IAW, AGW, and IGW 
who are 30 years or younger (IAW = OR ≥ 5.479; AGW = OR ≥ 3.822; IGW = OR ≥ 
1.571; respectively) have a greater chance of being diagnosed with cervical cancer as 
compared to older women from the same ethnic group who are 55 years and older (IAW 
= OR ≤ 2.797; AGW =OR ≤ 2.483; IGW = OR ≤ 1.232 respectively). This seems to 
indicate that the younger women in each ethnic group have a greater chance of being 
diagnosed with cervical cancer as compared to older women in the same ethnic group. 
These findings are consistent with the results from previous studies that showed a 
relationship between increased age and increased incidence of cervical cancer (Pierce 
Campbell et al., 2012; Roue et al., 2012) as well as a higher age-standardized incidence 
of cervical cancer among Indigenous women (Shannon et al., 2011). Guyana has a mixed 
healthcare system consisting of universal healthcare and private practices. Healthcare is 
primarily practiced as treatment-based rather than preventative, which could be 
understood in the context of limited financial and healthcare worker resources. At the 
start of the Guyana Cancer Registry, data was mostly collected through visits to 
healthcare facilities. My finding that showed younger women were more likely to be 
diagnosed with cervical cancer than older women indicates that in the absence of any 
voluntary cervical cancer screening program, younger women would have been more 
likely to visit health facilities than older women. Visits might have included prenatal 





to be seeking such care. It is also possible that physician bias could lead to low levels of 
diagnosis for older women. Physician bias occurs when a physician assumes that older 
women who may not be sexually active would not need to be screened for STDs. 
Cervical cancer may take 10-15 years from onset to become invasive (Anderson et al., 
2015). Older women are also more likely to associate early symptoms of cervical cancer 
with the process of aging and other co-morbid conditions; hence they are not inclined to 
seek medical attention. This possibly explains the findings from this study that older 
women were more likely to be diagnosed with later stage cervical cancer. Comparative 
studies of breast cancer in developing countries also showed that older age has been 
associated with the delay of patients seeking treatment (Ramirez et al., 1999).  
With regards to the marital status, my findings from this study showed that 
married AGW have a greater chance of being diagnosed earlier for cervical cancer than 
single AGW (OR = .962; p < 0.05). All single IAW are more likely to have higher rates 
of cervical cancer when compared to their married counterparts. The relative risk of 
developing cervical cancer for single IAW is greater than married IAW. This information 
indicates that factors such as younger age, single marital status, number of sexual 
partners, and co-habitation without marriage, as well as high parity, rural residence, low 
socioeconomic status and lack of access to healthcare facilities might be responsible for 
the increased risk of HPV infection which contributes to the development of cervical 
cancer.  
Findings from other researchers show that for the Indigenous population, the 





age (18-26 year age group, and 31-40 year age group), cohabitation without marriage, 
and current smoker (Brassard et al., 2010; Garland et al., 2011; Reiter et al., 2013; Soto-
DeLeon et al., 2009) were associated with a higher prevalence of HPV among Indigenous 
women. Additionally, other studies have reported that Indigenous women have higher 
risks of developing cervical cancer and less chance of survival rates than non-Indigenous 
women (Roue et al., 2012; Shannon et al., 2011; Vasilevska et al., 2012). For the AGW 
discussed in my study, the relative risk between single and married AGW was not 
significant. This is more likely because Afro-Guyanese live in areas where healthcare 
facilities are easily accessible and their socioeconomic status is relatively the same 
between the single and married women. Additionally, in all three ethnic groups discussed 
in my study, divorced women appeared less likely to develop cervical cancer when 
compared to married and single women. Currently, no other research study has examined 
the marital status among IAW, AGW, and IGW in Guyana. These findings could have 
future implications for addressing the incidence of cervical cancer among these three 
ethnic groups of women. 
Marital status was only significant for the distant stage as compared to the in-situ 
stage. Findings from this study found that for the distant stage, as a single woman’s 
marital status was changed to married or divorced, she had a 53% less chance of moving 
to the distant stage when compared to the in-situ stage. This information implies that 
single women are more likely to be in the distant stage when compared to married or 
divorced women. Among the three ethnic groups of women discussed in this study, most 





stage (15.8%), and then the distant stage (10.9%). These results indicate that diagnosis of 
cervical cancer was made late. Relative to the increased age of the women, there was less 
likelihood of the cervical cancer cases being localized, with cervical cancer cases for the 
older age group more likely to be in situ stage. Cervical cancer cases that were diagnosed 
later were more likely to be in the in situ stage. There was a 1.228 times more probability 
of getting to the localized stage; 1.319 times more probability of getting to the regional 
stage; and 1.356 times more probability of getting to the distant stage. These findings 
suggest that with increasing age, there is an increased likelihood of women moving into 
the critical stages and being diagnosed late. 
Previous studies which examined the association between late stage diagnosis of 
cervical cancer and insurance and age found similar results (Printz, 2012). Risk factors 
that were identified by Printz (2012) as being associated with late stage diagnosis of 
cervical cancer were socioeconomic status, race, marital status, and geographic location 
Therefore, women are more likely to advance to the distant stages of cervical cancer as 
they become older. 
Compared to married or divorced women, my finding showed that being single 
was associated with the distant stage at diagnosis of cervical cancer. As a single woman’s 
marital status was changed to married or divorced, she had a 53% less chance of moving 
to the distant stage when compared to the in-situ stage. This information implies that 
single women are more likely to be in the distant stage when compared to married or 
divorced women. The association between marital status and the stage at diagnosis of 





contracting cervical cancer. Previous studies have shown that being single, marital status 
and aboriginal background were risk factors associated with high-risk HPVs (Brassard et 
al., 2012). 
With regards to geographical regions, as the regions become denser with the 
number of cervical cancer cases, the stage at diagnosis is also a critical factor. My finding 
showed that compared to the in-situ stage, as the population density increases, women are 
more likely to be diagnosed at the localized, regional, and distant stages (OR = 1.753; OR 
= 1.803; and OR = 1.754 respectively), particularly for each cervical cancer case in the 
in-situ stage, where there would be about 1.75 times more cases for those women who are 
in the localized, regional, and distant stages. These findings provide evidence-based 
information for primary prevention such as early detection for cervical cancer for all 
women within their geographical regions, especially among the IAW who reside in rural 
areas and do not have the quality of care or adequate access to healthcare care services. 
Limitations of the Study 
This study was limited to the use of existing data that were obtained from the 
Guyana Cancer Registry between 2000 and 2012. Data completeness and quality were 
not assessed during this study period; therefore the quality of the data could impact the 
validity of the estimates and sampling errors. The current reporting requirements to the 
Guyana Cancer Registry is not bound by a legal mandate (P. Layne, personal 
communication, March 30, 2016), hence the likelihood of underreporting of data. Not 
having sufficient information on the data collection process might have produced biases 





cervical cancer data coverage in the rural areas of the study region. Although data from 
the cancer registry were provided for all the regions, the combined case counts (both the 
crude case count and case rate)of the cervical cancer cases for some regions (Regions 1, 
7, 8 and 9) were very low(<4%), and were therefore excluded from the data analysis. My 
findings might not reflect the true magnitude of the cervical cancer cases within the study 
area. It is therefore assumed that the cervical cancer case counts might have been higher 
within the rural areas and underreported for IAW due to the geographical barriers that 
exist in reaching this population. The cultural and religious practices which could impact 
how IAW seek medical help were not addressed in this study. Additionally, crude case 
rate used in this study was only based on the 2002 census data. Using only cervical 
cancer cases instead of incidence rates for IAW, AGW, and IGW limited the analysis on 
these three ethnic groups of women. Denominator data was not available to calculate 
incidence rates from the data provided by the Guyana Cancer Registry. Also, the regional 
ethnic distribution data was not available for 2012. The female population count per 
ethnic group and region, as well as the ethnic regional distribution for the 2012 census 
were not available. Although my findings could provide meaningful information for 
program planning, incidence rates would have enabled a better understanding of the 
disease where the populations differ in size as well as to compare disease occurrence 
during different time periods (Gregg, 2008). 
Implications for Social Change 
This study has important implications for the Guyana Ministry of Health, the 





findings showed that IAW had a higher risk of getting cervical cancer as compared to 
AGW and IGW. Similarly, the results from previous researchers also showed that IAW in 
Guyana have a high rate of cervical cancer (Kightlinger et al., 2010). In contrast, other 
researchers found that Indigenous women had a significantly lower risk for cervical 
cancer than non-Indigenous women and which might have occurred as a result of the 
underreporting of cervical cancer rates especially among the Indigenous women (San 
Sebastian & Hurtig, 2004). These findings of San Sebastian & Hurtig (2004) are similar 
to the finding from my study, which showed that the lower rates of cervical cancer for 
IAW were due to underreporting. The data obtained from the Guyana Cancer Registry for 
IAW who were sampled, were small (one-third of the Amerindian population) and thus, 
indicate that IAW are disproportionately affected by cervical cancer. More reporting of 
data for IAW in Guyana could mirror the high rates as reported in Kightlinger and 
colleagues (2010) findings.  
The differences in the sociodemographic, environmental, contextual, and cultural 
factors, in addition to the findings from my study showed there were significantly higher 
cervical cancer cases among IAW. Geographic variations of cervical cancer cases among 
the three groups of women are avenues that should be further explored. Public health 
interventions are necessary to address the existing disparities among IAW, AGW, and 
IGW within the urban/coastal and hinterland regions. The design of effective cervical 
cancer prevention programs to ensure monitoring and surveillance should be considered.  
Findings from this study could also be used to guide program planners in 





cervical cancer issues at the individual, interpersonal, cultural, and community levels. To 
assess the accuracy of cervical cancer case reporting among the ethnic groups of women 
discussed in this study, a national cancer registry should be implemented to track all 
cervical cancer cases in Guyana. Legislation is needed to enable mandatory reporting to 
the cancer registry for all cervical cancer cases from both public and private health 
facilities. This would close reporting gaps and enable a more accurate cancer registry. 
Recommendation for further study to assess the overall performance of the Guyana 
Cancer Registry in relation to the acquisition of data from both public and private health 
care facilities where cervical cancer is diagnosed and treated is needed. In the future, data 
from a viable cancer registry could be used for extensive research and treatment plans for 
cervical cancer. 
In addition, appropriate measures to enhance the data collection process, as well 
as increased cervical cancer programs and better health services, are warranted. 
Appropriate telecommunication technology, especially in areas where infrastructure is 
limited, should be addressed. Personnel would have to be trained on its use. However, 
drawbacks to this implementation could occur as a result of lack of financial expenditure 
to install and administer this technology, and security issues relating to personal data 
because wireless data is not considered a secured mode of telecommunication. Another 
measure that could be utilized is the establishment of mobile clinics to execute programs 
and to increase awareness of cervical cancer through education, as well as to improve 
data collection. However, these clinics would have to be appropriately staffed. The 





recommended for Indigenous Amerindians to become healthcare practitioners to work in 
the remote areas. Providing adequate incentives could be a means of attracting more 
healthcare workers to the remote regions. The training of healthcare workers to avoid 
physician bias should also be conducted and incorporated into the training of all 
healthcare personnel. Also, larger scale Visual Inspection with Acetic Acid (VIA) 
screening programs to include older, post-menopausal women is recommended.  
Recommendations for Future Research 
The data presented in this study suggest that IAW are disproportionately affected 
by cervical cancer outcomes compared to AGW and IGW. The Guyana Cancer Registry 
data excluded more than 50% of the Indigenous Amerindian population. The Cancer 
Registry should extend its surveillance capability by conducting periodic surveys as well 
as to conduct HPV immunizations earlier among the IAW. It may also be beneficial to 
assess the completeness of the cervical cancer reporting and HPV immunization rates 
among the IAW, and to find ways to improve the reporting requirements for this 
population. The results from this study should guide future research in exploring 
geographical variations in the incidence rates of cervical cancer in Guyana among IAW, 
AGW, and IGW. Epidemiological research which includes geospatial analyses could 
further provide a better understanding of the distribution patterns of cervical cancer 
within the ten regions. 
This study provides insight on cervical cancer among three ethnic groups of 
women in Guyana. Findings on the study variables (adjusted age, marital status, 





that further research is necessary to address the contributing factors related to the 
increasing cervical cancer cases in Guyana.  
Recommendations for future research should include: (a) an assessment of 
underreporting to enable a more accurate profile of cervical cancer in Guyana. This could 
serve as a basis for mandatory reporting to facilitate future cancer research; (b) stratifying 
cervical cancer incidence in order to create the insights needed from more detailed 
analyses and geospatial considerations within the ten regions of Guyana; (c) 
implementing screening programs to test for HPV, HIV, HBV and HCV throughout the 
ten regions, particularly in those rural and urban regions that experience cervical cancer 
disparities; (d) conducting research on the cultural norms of IAW, AGW, and IGW to 
address lack of knowledge about cervical cancer among these three group of women, and 
for healthcare providers and community public health workers to develop culturally 
appropriate cervical cancer prevention programs; (e) examining evidence-based cervical 
cancer intervention and control strategies for IAW, AGW, and IGW throughout the 
regions of Guyana; (f) engaging leaders from the Indigenous Amerindian communities to 
discuss the health needs of their people and to use this information to guide program 
planning to address these needs in culturally, appropriate ways; and (g) obtaining more 
resources to reach underserved areas, and  conducting outreaches and special surveys 










In conclusion, this is the first study to use cancer registry data from Guyana to 
examine the relationship between cervical cancer cases and demographic factors among 
IAW, AGW, and IGW. My study provides several distinct key findings: First, differences 
exist between the observed and expected cervical cancer cases between AGW when 
compared to IAW and IGW. The expected count of cervical cancer cases for AGW was 
less than the observed count, while for IGW and IAW, the expected counts were greater 
than the observed counts. This suggests there was a possible underreporting of cervical 
cancer diagnosis for both IGW and IAW, where the populations are larger in the remote 
areas, and with minimal access to health care facilities (See Table 7).There were also 
differences in the case rate between these groups of women in the study region; IAW had 
the lowest case rate (1.2 per 1000 as compared to 2.55 and 1.41 per 1000 for AGW and 
IGW respectively). Second, geographical region was a strong predictor of cervical cancer 
when comparing the different ethnic groups of women. Third, age was a strong predictor 
of cervical cancer among the three groups of women. Younger women have a greater 
chance of being diagnosed with cervical cancer because of the likelihood of migrating to 
areas where access to healthcare is available. Migration trends in Guyana from remote 
rural to urban areas would enable more access to health service centers. Most of this 
migration is likely to occur among the younger, mobile population than the older women. 
This indicates that younger women may have had more reported diagnosed cervical 
cancer cases into the Cancer Registry than older women. Marital status was only 





beyond 2010, was an important predictor of cervical cancer among IGW. This indicates 
there was an increase in health expenditures among the IGW. However, there is no 
census data relating to health expenditure capita for ethnic groups or geographic regions. 
According to the World Bank (2016a), in Guyana, the health expenditure as a percentage 
of GDP decreased between the years 2011 to 2014, while health expenditure per capita 
rose from $232 million US dollars in 2011 to $247 million in 2012. In 2014, however, 
there was a decrease in health expenditure per capita of $222 million in 2014 (World 
Bank, 2016b). Fourth, my findings showed that older women were more likely to be 
diagnosed with late stage cervical cancer.  
Cervical cancer is a preventable disease. My findings could provide further 
insights to address the burden of cervical cancer cases among IAW, AGW, and IGW. The 
high rates of cervical cancer in Region 4 indicate there is a need to develop better health 
education programs and improved health services. Overtime, with the development of 
better infrastructure, the Guyana cancer registry would be able to have more extensive 
data. Also, a better reporting system would enable a more accurate profile of the cervical 
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